hg_139014.1

Basic information about the TSS

---

TSS ID: hg_139014.1 Species: human Chr: chr14		Start: 24232438 End: 24232524 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000559836.5 ENST00000561038.5 BX161436 AF135159 Distance: 0 GeneID: 51292 HGNC/MGI_ID: HGNC:4377 UniProt_ID: A0A0B4J281 Q9P2T1

Gene_name: guanosine monophosphate reductase 2 Gene_symbol: GMPR2 Gene_synonyms: Gene_source: HGNC:4377

TATA-Box annotation

---

Distance to TSS:	-96
Nearest PromoterID:	NM_001199823
Entrez ID:	100528064
Nearest Unigene:	Hs.220963
Nearest Refseq:	NM_001199823
Nearest Ensembl:	ENSG00000255526
Gene Name:	guanosine monophosphate reductase 2
Gene Alias:	-
Gene Description:	NEDD8-MDP1 readthrough
Gene Type:	protein-coding
CpG%:	0.06
GC%:	0.59204
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GMPR2 p2@GMPR2 p3@GMPR2 p4@GMPR2 p5@GMPR2 p6@GMPR2
Sample		p1@GMPR2	p2@GMPR2	p3@GMPR2	p4@GMPR2	p5@GMPR2	p6@GMPR2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	5.65	4.29	3.51	5.06	0.39	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.71	6.68	4.86	2.83	0.20	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	8.68	6.56	3.09	5.21	0.58	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	8.11	4.99	2.08	3.12	0.83	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	9.90	3.82	2.70	4.72	0.67	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.14	5.62	2.91	5.81	0.39	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	12.64	6.75	6.97	6.75	1.09	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	11.14	7.27	6.54	7.02	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.90	5.56	3.85	5.56	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.75	3.48	10.43	5.80	1.74	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.57	5.26	6.06	4.45	1.21	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	15.45	4.88	6.50	4.47	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.98	5.64	7.90	2.26	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	23.45	7.37	7.97	1.65	1.50	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	27.01	5.05	6.37	1.32	1.10	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	25.90	7.04	7.04	1.76	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	21.84	5.90	8.95	2.18	1.09	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.09	7.17	8.86	2.95	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	27.72	6.93	7.46	1.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	29.34	7.37	7.97	0.45	0.90	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	26.86	6.42	6.55	1.60	0.80	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.99	5.87	6.21	1.21	0.86	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	24.82	6.08	8.53	1.68	0.65	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	27.18	4.61	8.01	2.43	1.70	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	25.28	4.90	7.48	1.81	1.55	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	25.32	8.55	8.55	1.27	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	24.18	6.59	7.69	2.20	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	32.53	6.84	7.07	2.59	1.41	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	29.88	4.85	7.27	2.26	1.13	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.79	5.61	7.60	1.99	1.09	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	26.80	5.86	5.44	1.05	1.26	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	24.03	4.30	8.01	1.37	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	25.75	8.44	7.60	2.32	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	35.30	7.09	10.23	2.47	1.65	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	21.13	6.54	6.73	1.50	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	22.61	4.60	6.71	1.92	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	22.69	6.74	5.93	1.64	1.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	21.36	6.65	5.64	1.81	1.81	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	26.74	3.51	9.18	1.35	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	23.05	5.04	7.68	2.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	17.88	4.23	6.35	2.82	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	26.79	6.59	7.76	2.49	1.61	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	26.99	8.65	6.96	1.90	2.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	20.45	4.72	5.77	2.80	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	23.09	5.42	7.23	2.61	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	26.52	4.65	4.65	2.56	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	21.11	7.92	6.48	2.88	1.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	26.82	6.26	5.66	2.38	2.09	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.83	7.18	4.79	3.35	1.91	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.23	6.87	6.67	3.44	0.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	22.54	6.76	6.35	3.28	2.05	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	20.90	6.67	8.01	4.00	1.11	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	19.52	7.10	4.26	2.84	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.23	6.96	4.64	2.98	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	31.04	11.75	7.55	4.19	5.87	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	22.96	7.81	5.05	3.67	2.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.96	6.48	3.89	4.21	2.92	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	14.13	5.14	4.18	1.61	1.93	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	29.86	9.12	8.49	3.46	2.51	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.28	4.23	2.12	2.82	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.78	5.61	3.36	4.49	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.90	6.37	3.98	1.59	3.18	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.78	5.44	4.42	4.08	1.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	8.45	4.22	2.27	1.62	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.71	4.26	4.97	2.13	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	16.16	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	5.36	3.41	4.88	2.93	0.98	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	10.41	5.45	3.47	4.96	1.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	5.16	5.16	1.88	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	10.93	5.30	6.29	3.31	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	7.11	6.50	4.95	2.47	1.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.56	3.97	3.36	1.22	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	9.98	9.19	2.53	3.48	0.79	0.00
Adipocyte - breast, donor2	11327-117E4	7.38	7.86	3.85	2.57	1.12	0.16
Adipocyte - omental, donor1	11473-119C6	12.47	11.83	3.18	3.18	1.02	0.38
Adipocyte - omental, donor2	11474-119C7	12.71	9.72	2.24	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	17.08	7.37	3.01	1.34	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	13.40	7.66	3.83	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	1.10	2.20	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.87	4.97	2.26	1.35	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	15.81	3.82	1.91	1.39	0.52	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	14.08	5.28	3.72	3.13	0.98	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	10.55	3.60	1.80	1.54	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	9.76	6.69	2.23	1.12	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	5.29	9.40	1.18	2.94	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	7.08	6.68	2.25	2.41	0.88	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	7.10	5.16	1.94	1.61	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	5.33	3.73	3.73	2.67	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	6.12	6.12	1.67	4.45	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	4.57	6.65	3.74	2.91	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	4.02	5.27	1.26	2.51	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	6.22	8.18	1.96	1.96	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	3.35	6.70	1.52	2.44	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	7.51	7.96	1.55	5.75	1.10	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	1.43	2.15	0.72	1.08	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	3.59	1.20	0.00	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	12.77	14.03	4.50	3.24	0.90	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	6.69	1.67	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.42	11.51	2.88	3.29	1.64	0.21
Anulus Pulposus Cell, donor1	11248-116E6	36.16	18.88	9.38	2.40	2.75	0.69
Anulus Pulposus Cell, donor2	11463-119B5	21.55	15.92	6.86	1.22	1.47	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.49	7.64	2.70	2.25	1.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.38	14.33	3.04	3.91	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	17.12	4.28	4.28	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.07	8.37	2.69	2.69	0.90	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	15.18	6.32	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	10.56	4.62	1.98	1.32	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.40	11.70	4.22	2.60	1.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	7.77	16.99	1.94	3.40	1.46	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	11.28	10.69	4.16	5.34	2.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	5.65	7.91	3.01	4.14	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	12.34	2.90	6.53	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	11.28	5.02	2.51	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.68	10.87	3.95	3.62	2.97	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	8.19	0.00	2.73	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.05	11.76	4.22	2.87	1.66	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.97	9.64	6.43	3.21	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.82	10.20	3.40	3.40	2.27	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.82	11.49	3.74	5.35	1.34	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	7.80	7.80	1.95	3.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.46	9.45	2.65	1.82	1.16	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	7.20	2.40	3.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	3.54	10.62	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.03	10.29	3.60	3.95	1.72	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	16.78	12.58	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	8.74	11.65	5.83	3.88	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.49	8.35	3.04	3.79	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	8.48	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.69	12.54	1.71	2.85	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.83	10.47	2.99	2.78	0.86	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.71	9.55	2.58	2.32	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.04	10.32	3.75	5.63	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.79	7.07	1.93	4.50	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	9.27	2.85	3.57	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.02	14.04	2.34	3.51	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.13	11.74	1.20	2.41	1.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	5.94	3.56	7.13	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.14	16.27	2.03	3.56	2.54	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.88	8.15	3.31	3.31	1.53	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	9.53	8.90	1.91	3.18	3.18	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.08	10.79	2.16	3.02	2.16	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	8.04	8.04	1.69	1.91	1.69	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.25	9.28	2.03	2.61	1.16	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	10.39	19.84	4.72	2.83	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.63	7.63	3.05	2.54	1.53	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	4.63	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	8.45	4.23	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.01	8.79	2.79	3.65	1.93	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.22	14.44	2.41	3.61	3.01	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	6.56	12.39	3.64	3.64	2.19	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.11	9.66	3.45	3.91	0.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	0.00	2.55	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	12.71	14.24	3.81	5.59	1.53	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.88	10.12	2.48	2.68	1.65	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.34	7.96	1.84	1.22	1.53	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.69	10.99	4.78	2.39	1.91	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	8.87	10.87	3.55	3.99	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	12.21	4.58	3.05	4.58	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.08	9.97	2.22	3.88	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	7.41	12.71	1.85	5.03	1.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.45	12.36	2.54	4.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	11.05	8.23	4.79	1.60	0.61	0.49
Astrocyte - cerebellum, donor2	11580-120F5	6.68	4.96	3.08	1.03	0.68	0.34
Astrocyte - cerebellum, donor3	11661-122F5	2.94	5.24	1.89	0.42	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	18.82	13.59	7.67	2.44	2.09	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	11.65	10.68	7.60	3.07	2.10	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	8.05	4.62	5.97	2.54	0.60	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	8.60	9.40	7.00	2.41	1.03	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	8.64	7.89	8.39	2.38	0.38	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	7.06	9.79	5.58	2.50	1.14	0.34
Basophils, donor1	12241-129G9	14.38	9.68	0.52	8.89	0.52	0.00
Basophils, donor2	12242-129H1	9.74	10.82	1.44	3.97	2.16	0.00
Basophils, donor3	12243-129H2	12.94	3.53	0.73	2.65	1.47	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	7.98	5.82	1.94	0.22	1.08	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	1.37	1.37	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.06	5.02	4.39	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	9.36	8.32	1.46	2.08	1.25	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	15.66	8.75	4.15	1.61	1.15	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	12.78	7.20	2.70	0.54	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	16.80	17.00	5.67	1.96	3.50	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	24.92	17.70	5.82	1.63	1.63	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	44.45	13.11	4.80	7.35	2.24	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	14.09	5.64	0.56	1.13	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	7.05	3.34	0.19	2.41	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	6.59	3.29	0.88	1.98	1.10	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	36.51	9.91	1.98	2.55	3.96	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	30.33	14.03	3.41	2.65	4.17	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	28.27	16.77	3.29	2.96	4.27	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	12.29	4.05	0.58	7.08	2.17	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	6.34	3.32	0.60	2.41	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	10.90	3.55	0.24	5.92	1.42	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.87	0.67	0.84	5.69	0.67	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	5.52	1.38	0.55	1.93	0.83	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	5.45	1.24	0.00	5.70	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	7.24	1.17	0.20	4.31	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.12	1.60	0.00	5.16	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	13.06	2.61	0.87	7.18	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	9.60	1.40	0.23	6.79	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	8.98	1.58	0.00	8.45	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	8.87	1.11	0.00	5.55	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	9.67	2.97	0.74	6.10	0.30	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	7.98	1.40	0.40	3.79	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	13.53	1.46	0.21	5.41	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.86	2.75	0.00	9.15	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	10.18	1.36	0.00	5.20	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.55	0.87	0.00	4.80	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	9.68	2.69	0.27	5.11	1.88	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	13.43	1.40	0.00	5.23	0.52	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	10.94	2.95	0.42	8.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.51	0.73	0.37	3.67	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.23	0.70	0.35	2.47	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.26	0.44	0.44	2.63	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6.63	3.14	0.87	8.54	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	8.18	1.86	0.00	4.09	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	14.66	1.94	0.00	10.99	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	8.19	2.05	0.41	4.50	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	7.42	0.93	0.00	3.94	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	9.74	0.93	0.46	7.19	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	21.58	11.12	1.31	3.27	1.53	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	23.79	12.47	1.85	3.93	1.62	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	24.04	11.70	1.73	5.42	3.90	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	21.49	14.01	1.87	6.07	5.45	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	25.15	12.05	1.22	5.76	3.49	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	13.38	7.80	0.89	4.68	2.01	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	26.54	15.31	3.32	6.89	2.55	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	24.37	11.64	3.95	5.05	1.54	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	25.05	15.37	4.00	5.68	3.16	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	34.55	6.10	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	14.24	23.05	8.81	6.10	2.03	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	13.46	33.14	6.21	3.11	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	18.12	18.12	6.93	7.46	3.20	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	24.12	31.63	10.19	1.07	2.14	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.93	21.06	4.21	0.00	2.11	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	19.61	21.18	6.27	0.00	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	17.14	30.32	13.18	1.32	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	9.86	13.15	1.64	0.82	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	9.43	3.63	2.18	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	11.11	3.03	1.51	0.50	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	3.64	9.29	1.62	7.68	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.59	11.19	2.80	8.79	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	28.11	9.04	3.01	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	25.84	4.49	1.69	1.69	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	33.44	13.90	4.88	2.63	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	39.46	14.88	6.76	5.64	4.74	0.45
CD4+ T Cells, donor1	11225-116C1	8.93	15.00	1.43	3.93	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	4.29	6.74	1.22	3.06	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	3.96	14.03	2.13	5.18	0.61	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	5.62	36.24	4.59	6.89	5.36	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	5.39	38.86	4.27	4.49	4.72	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	7.47	33.06	5.17	4.60	4.31	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	6.16	32.24	5.69	1.90	2.37	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	15.45	48.46	7.02	2.11	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	32.96	6.59	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	22.98	45.23	9.83	13.44	9.68	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	8.47	41.01	4.24	8.47	5.08	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	9.83	33.05	7.25	8.71	4.03	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	9.86	37.66	5.38	4.48	4.48	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	4.19	49.61	2.80	5.24	4.54	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	10.12	43.56	2.64	3.08	4.40	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	4.64	36.68	2.11	4.64	3.79	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	1.66	29.50	2.08	4.78	2.91	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	2.00	31.41	2.67	3.01	3.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	8.43	37.80	2.99	4.89	2.45	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	12.33	39.12	2.14	2.14	3.75	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	7.17	25.11	3.59	5.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	6.68	37.09	3.71	6.30	5.93	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	4.98	31.84	3.03	5.63	5.42	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	4.41	38.04	3.78	8.20	3.99	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	5.56	38.43	3.54	6.07	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	9.10	40.29	6.93	1.73	6.93	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	8.72	25.71	2.61	4.36	5.67	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	14.85	45.03	4.95	6.43	8.91	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	5.54	49.85	3.69	7.39	4.62	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	8.37	57.23	4.19	4.19	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	16.62	48.74	4.43	3.32	3.32	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	13.50	60.61	7.12	3.68	4.66	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	9.24	55.44	3.08	4.62	1.54	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	8.59	54.43	3.58	5.37	6.80	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	8.31	72.02	2.77	2.77	11.08	0.00
CD8+ T Cells, donor1	11226-116C2	5.89	11.79	3.27	5.89	1.64	0.33
CD8+ T Cells, donor2	11307-117C2	4.13	10.51	1.50	1.88	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	5.30	11.11	2.27	2.02	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	8.72	3.90	3.67	2.06	0.46	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.43	4.31	2.64	1.44	0.48	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	7.66	3.83	2.19	1.64	0.55	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.01	4.80	3.60	1.20	0.00	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.24	2.40	2.88	0.24	0.48	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	7.28	4.78	2.96	1.36	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	4.35	2.82	1.96	1.52	0.87	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.74	3.42	2.63	2.11	0.53	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	6.80	2.35	3.28	0.94	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	5.43	3.92	4.83	1.51	1.21	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	4.65	3.49	6.39	2.32	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	5.33	3.20	1.60	2.66	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	7.00	2.19	3.50	1.75	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	5.01	2.28	1.37	2.73	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	5.22	1.49	0.75	2.98	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	6.84	3.60	2.52	1.08	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.48	5.75	2.88	3.74	0.86	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.19	2.83	3.54	2.36	0.71	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	6.34	2.85	2.54	1.27	0.63	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	5.84	4.00	3.38	1.54	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.77	3.53	1.28	2.24	0.00	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	6.50	2.29	3.82	0.38	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5.12	1.58	2.76	0.79	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	2.27	2.27	1.51	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	10.44	4.01	5.62	1.61	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	11.89	2.80	9.79	2.10	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	14.02	3.01	5.01	0.00	1.00	3.01
Cardiac Myocyte, donor1	11525-119I4	7.31	10.97	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	12.35	4.94	3.95	0.99	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	10.42	7.89	2.84	1.79	2.21	0.21
Chondrocyte - de diff, donor1	11261-116G1	17.33	11.09	2.43	4.16	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	25.94	9.60	3.20	5.33	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	21.28	10.47	3.75	3.87	1.14	0.46
Chondrocyte - re diff, donor2	11339-117F7	20.59	8.95	4.48	4.48	3.58	0.00
Chondrocyte - re diff, donor3	11411-118E7	11.73	4.85	2.43	2.02	2.02	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	20.20	10.90	8.03	1.84	1.49	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	7.91	10.47	3.85	2.35	1.07	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	10.89	8.23	5.75	1.86	2.21	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	12.84	16.96	6.51	4.77	2.11	0.92
Corneal Epithelial Cells, donor1	11526-119I5	6.81	7.69	1.76	0.88	1.32	0.00
Corneal Epithelial Cells, donor2	11606-120I4	6.83	10.24	3.41	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.39	4.86	2.30	1.02	1.02	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	6.11	11.89	0.99	2.97	1.32	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	5.36	10.09	0.95	2.52	5.05	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	17.25	3.45	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.13	9.50	1.19	3.56	2.48	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	25.62	9.57	2.73	1.37	3.42	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	19.59	12.40	1.31	1.96	2.61	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	24.68	7.26	1.45	1.45	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	3.67	6.67	1.33	3.50	3.34	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	2.93	7.04	0.59	4.69	2.93	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	4.81	6.50	0.28	3.96	1.98	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	3.54	6.29	1.18	3.93	1.97	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.24	8.14	2.33	6.98	2.91	0.00
Endothelial Cells - Artery, donor2	11341-117F9	4.47	7.76	0.94	7.76	3.53	0.24
Endothelial Cells - Artery, donor3	11413-118E9	2.45	7.36	0.70	5.61	4.03	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	5.76	14.63	0.00	4.65	5.76	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	2.13	11.56	1.22	4.87	5.78	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	2.82	15.22	1.13	4.51	4.23	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	5.94	12.48	0.89	5.05	1.49	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	4.69	7.29	2.08	5.21	3.64	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	1.84	9.22	0.99	3.40	3.54	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	7.20	12.40	1.60	5.20	2.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	2.10	8.39	1.05	4.19	4.19	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	8.45	19.01	3.48	9.19	7.83	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	5.21	4.56	0.65	3.04	3.26	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	3.42	6.35	1.34	4.89	3.05	0.00
Endothelial Cells - Vein, donor1	11267-116G7	6.83	2.28	2.28	5.69	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	5.59	6.99	0.00	4.89	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	3.61	6.75	2.20	5.50	3.93	0.00
Eosinophils, donor1	12244-129H3	15.25	30.49	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	1.65	4.95	0.00	87.46	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	3.57	0.00	67.77	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	8.80	3.18	1.47	1.47	1.47	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.44	4.52	0.41	1.64	2.05	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.72	4.38	1.42	2.52	1.42	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.69	6.39	2.49	2.71	0.98	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	9.22	9.34	3.76	6.67	1.82	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	9.96	20.61	2.18	7.78	4.23	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.65	6.22	1.48	2.64	1.58	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	9.22	13.44	3.43	2.37	1.32	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	5.98	6.31	2.66	3.99	1.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	11.79	9.07	3.18	4.08	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	5.31	9.10	2.27	5.31	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	3.00	4.42	2.05	3.31	0.95	0.16
Fibroblast - Cardiac, donor4	11452-119A3	12.12	11.21	4.55	1.82	0.91	0.30
Fibroblast - Cardiac, donor5	11456-119A7	11.29	9.64	3.43	2.41	1.52	0.00
Fibroblast - Cardiac, donor6	11460-119B2	3.79	8.03	2.27	3.03	1.36	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.05	11.26	3.62	2.95	0.67	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	5.61	2.59	1.73	3.02	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	5.86	10.25	1.46	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	10.38	6.92	4.38	3.00	2.08	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	30.70	15.43	5.26	2.20	1.02	0.51
Fibroblast - Dermal, donor1	11269-116G9	11.97	8.45	4.70	1.64	1.17	0.47
Fibroblast - Dermal, donor2	11346-117G5	11.32	8.02	0.47	2.83	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	11.97	8.70	4.11	0.97	1.57	0.00
Fibroblast - Dermal, donor4	11450-119A1	9.61	9.38	4.75	3.17	1.47	0.11
Fibroblast - Dermal, donor5	11454-119A5	12.91	9.94	4.54	5.93	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	14.78	8.12	3.90	3.41	0.49	1.14
Fibroblast - Gingival, donor1	11237-116D4	22.91	11.04	8.75	1.46	2.29	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	12.58	13.62	3.93	2.36	1.83	0.26
Fibroblast - Gingival, donor2	11318-117D4	11.47	11.07	6.06	2.64	1.71	0.13
Fibroblast - Gingival, donor3	11394-118C8	22.33	6.96	5.32	1.64	1.16	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	13.51	10.39	2.08	5.19	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	8.81	4.58	1.94	1.94	1.06	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	9.67	8.42	2.18	4.52	1.09	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.41	7.44	4.06	3.52	0.68	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	2.82	4.94	2.12	4.23	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	10.53	8.04	4.39	3.80	0.58	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	6.68	9.27	5.18	2.45	1.91	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	8.01	6.58	3.40	3.73	0.66	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.11	5.58	2.79	4.11	0.88	0.29
Fibroblast - Lung, donor1	11270-116H1	9.52	6.80	1.36	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	13.43	7.46	2.98	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	9.92	8.23	2.95	2.53	2.11	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	1.67	0.83	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	2.80	1.40	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.24	1.12	1.12	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	12.59	13.40	3.65	5.28	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	11.91	0.00	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	13.19	17.07	9.12	5.43	3.30	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	11.53	7.74	5.31	3.64	2.28	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	14.69	11.02	4.28	2.75	1.22	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8.78	5.72	2.67	1.91	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.15	7.83	2.43	1.89	2.43	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	9.63	3.48	1.28	1.74	0.58	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	8.62	12.49	2.65	6.19	2.76	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	8.13	11.18	2.84	3.25	1.42	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	3.34	2.67	0.00	4.01	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	15.02	10.28	3.95	1.19	3.56	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	13.30	15.88	3.57	4.37	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	20.25	11.19	3.91	1.60	1.24	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	15.57	9.07	2.17	1.58	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	8.12	17.45	2.41	5.11	1.50	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	20.40	12.41	3.78	2.05	0.54	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	16.70	23.28	4.05	4.56	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	15.75	12.96	3.61	2.13	2.63	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	10.03	15.24	4.21	5.41	2.41	0.00
Fibroblast - skin normal, donor2	11561-120D4	11.65	10.95	3.62	1.81	1.11	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	15.11	18.13	6.35	4.23	2.72	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	21.54	10.77	4.64	2.73	2.40	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	41.20	9.92	7.52	1.54	1.03	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	10.51	20.03	2.63	4.60	1.97	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	11.18	10.23	3.09	2.24	1.17	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	12.48	11.47	3.71	3.88	2.36	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.00	8.00	4.08	2.35	3.45	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	88.64	0.00	22.16	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	0.00	7.84	3.49	0.87	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	5.55	15.95	1.73	5.55	1.39	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	7.81	10.15	1.82	2.60	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	5.11	8.43	1.79	6.13	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	52.82	5.36	13.01	5.36	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	54.24	8.93	15.95	5.10	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	42.50	10.84	4.85	4.56	0.86	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	35.85	6.62	10.20	1.65	0.83	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	20.09	8.45	9.36	1.60	1.83	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	34.67	5.75	7.13	4.76	0.79	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	32.51	8.46	9.52	3.44	1.06	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	11.09	9.13	5.22	3.59	0.98	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	41.13	5.31	6.19	5.75	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	32.08	8.62	5.23	2.12	1.13	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	17.86	6.77	6.16	1.60	0.25	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	27.40	6.98	5.37	2.95	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	13.38	3.72	3.96	1.73	0.62	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	19.52	4.84	5.40	1.38	0.69	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	25.01	5.49	2.64	2.03	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	17.80	7.07	5.48	2.51	0.68	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	15.45	4.98	4.98	1.74	1.12	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	13.77	5.90	3.93	1.75	1.09	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	24.82	7.68	6.80	0.59	1.18	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	16.53	8.27	4.61	2.54	0.79	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	14.30	6.03	3.35	0.67	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	16.33	4.23	5.44	1.41	1.01	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.93	8.65	9.16	2.37	1.19	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	17.20	8.96	5.94	2.48	1.68	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	23.10	12.28	6.14	1.77	1.66	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.96	8.37	6.49	1.37	2.05	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	13.94	11.29	8.08	1.55	1.55	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.72	7.90	7.40	2.41	1.66	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.42	7.96	8.17	2.25	1.63	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	16.71	10.32	7.63	1.44	0.83	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	12.80	9.68	7.61	2.31	0.69	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	18.18	7.00	5.50	2.00	1.50	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	19.40	8.60	7.49	1.32	1.54	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	15.25	11.81	5.90	1.48	1.23	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	11.18	8.27	7.46	0.97	0.97	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	18.60	8.66	8.34	0.96	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	13.36	6.82	5.78	1.33	0.76	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	12.97	7.75	4.11	1.27	0.95	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	13.99	12.47	5.17	1.22	0.91	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.45	7.00	4.50	2.30	1.36	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	16.69	9.22	4.61	1.10	1.54	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	11.50	5.05	6.17	1.68	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.13	7.68	4.17	1.85	0.46	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	9.09	8.82	3.74	3.21	1.60	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	6.12	8.11	5.36	1.84	1.99	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	6.61	8.42	4.27	1.55	1.42	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	11.39	9.76	5.15	0.81	1.08	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	9.77	8.85	4.06	1.47	1.84	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	9.87	9.65	4.82	2.41	1.97	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	18.84	13.88	4.96	2.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	7.39	8.71	2.64	1.58	1.58	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	7.26	7.26	2.22	2.02	1.01	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	17.03	11.95	4.32	0.76	1.52	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	59.72	11.55	4.98	3.38	0.80	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	30.51	7.09	4.16	1.54	0.31	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	40.51	8.80	6.34	2.45	1.02	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	68.84	6.26	10.01	3.44	1.88	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	66.68	10.17	10.74	2.83	0.57	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	57.65	6.92	8.30	1.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	4.95	0.00	9.90	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	36.36	5.03	6.58	2.32	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	48.13	12.84	8.02	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	41.73	8.69	10.43	3.48	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	40.03	6.51	8.46	2.93	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	42.42	6.18	9.06	1.24	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	10.00	6.66	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	34.96	8.39	6.71	1.68	0.56	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	35.63	6.21	7.84	0.65	1.63	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	35.23	5.03	5.03	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	40.71	6.04	9.22	0.95	1.91	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	39.74	7.81	10.53	1.02	0.00	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	71.00	4.18	12.53	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	50.97	10.31	13.17	1.15	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	39.07	7.10	6.81	0.30	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	38.97	11.86	11.86	0.00	3.39	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	33.14	6.21	11.18	3.31	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.45	8.28	8.28	1.15	1.61	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	10.54	21.07	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	37.29	5.77	11.15	1.54	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	45.64	6.52	10.43	0.00	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	40.13	9.36	16.05	0.00	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	58.95	9.25	11.94	0.00	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	33.89	6.50	8.56	1.03	1.37	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	4.97	9.94	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	58.98	10.85	9.44	1.89	0.47	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	53.11	3.62	12.67	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	52.90	8.14	13.23	1.53	1.53	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	43.87	6.78	11.97	0.40	0.80	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	56.24	9.37	12.33	0.49	2.47	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	57.84	8.26	12.98	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	57.18	5.83	10.50	1.17	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.45	8.34	7.90	1.76	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	39.84	5.09	10.17	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	40.59	4.78	7.76	2.39	0.60	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	27.66	6.79	9.22	0.49	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	4.57	2.28	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.40	6.24	2.49	0.83	2.08	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	6.75	5.62	7.87	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	28.23	6.98	3.49	1.59	1.59	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	41.77	7.94	5.01	2.09	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	13.11	9.28	5.69	5.22	0.81	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	9.96	11.65	6.08	5.57	1.18	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.47	11.60	3.87	5.46	1.82	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	10.28	8.85	5.47	5.57	1.31	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	11.82	12.04	3.87	4.94	0.86	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	8.61	9.26	2.37	5.38	1.08	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	10.71	9.34	4.98	5.73	0.75	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	8.06	10.12	4.63	4.80	1.20	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.05	8.97	7.37	6.73	0.96	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	1.68	5.60	0.56	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	0.00	3.03	0.00	1.30	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2.64	0.00	5.29	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.70	9.88	2.47	1.06	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	4.36	1.45	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.99	8.74	4.02	3.32	1.40	0.00
Hepatocyte, donor1	11523-119I2	8.47	19.37	2.42	4.84	2.42	1.21
Hepatocyte, donor2	11603-120I1	10.77	5.39	5.39	4.31	1.08	0.00
Hepatocyte, donor3	11684-122I1	6.14	4.91	3.07	2.45	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	9.79	30.68	8.48	7.83	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	35.13	12.58	10.84	2.27	1.92	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	7.96	8.23	3.02	1.78	1.92	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	6.37	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	13.35	0.00	13.35	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	8.31	6.92	8.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	7.51	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	7.69	5.13	5.13	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	6.50	3.25	6.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	6.67	0.00	1.67	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	3.63	3.63	7.26	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	7.94	2.65	3.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	3.33	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	10.48	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.15	5.04	3.15	6.30	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	3.09	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	4.52	3.23	1.29	3.88	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	6.44	1.61	4.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4.89	3.26	4.07	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.94	5.88	3.78	2.10	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	2.41	1.61	4.02	3.21	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	4.62	1.85	1.85	0.00	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2.83	2.83	1.89	1.89	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1.81	8.16	1.81	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	4.30	3.23	3.23	5.38	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2.54	5.08	2.54	7.62	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.74	7.65	2.55	3.19	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	1.82	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	3.57	5.00	1.43	1.43	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	3.32	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.86	5.56	2.47	4.94	0.31	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	5.27	8.78	5.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	6.29	0.00	6.29	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.17	5.56	0.70	5.56	1.39	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	4.43	2.21	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	6.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	7.85	4.36	4.36	3.49	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	0.00	6.75	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	10.45	0.00	10.45	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	3.20	5.33	3.20	3.20	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	6.93	2.77	0.00	2.77	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	14.25	2.85	8.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	4.60	0.00	2.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	12.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	6.34	4.23	2.11	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	10.61	15.26	2.69	2.45	2.77	0.16
Keratinocyte - epidermal, donor2	11349-117G8	9.37	6.44	3.51	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	11.93	10.70	3.50	1.80	1.61	0.19
Keratinocyte - oral, donor1	11251-116E9	38.71	20.89	7.49	2.61	3.75	0.34
Keratocytes, donor1	11527-119I6	14.78	9.28	2.06	5.16	2.06	0.69
Keratocytes, donor2	11607-120I5	5.86	4.69	3.52	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	12.25	3.56	2.96	1.78	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	10.79	9.71	4.31	5.39	4.31	0.00
Lens Epithelial Cells, donor2	11609-120I7	21.22	13.38	6.57	1.96	2.42	0.46
Lens Epithelial Cells, donor3	11690-122I7	7.47	6.26	2.93	2.02	1.41	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.52	14.82	2.13	6.64	4.86	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.07	10.88	1.67	4.47	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	5.04	11.65	1.26	8.50	3.94	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.23	11.83	2.69	8.60	2.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.15	7.88	0.63	5.99	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.39	10.67	2.05	7.98	3.45	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	2.05	7.80	1.64	6.16	2.46	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.08	9.35	1.26	6.57	3.29	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	5.35	11.96	1.27	6.19	2.11	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3.56	9.10	1.19	5.54	2.37	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.82	9.11	0.97	9.11	3.49	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.04	9.26	0.93	9.81	2.78	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.23	12.54	2.09	6.62	3.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.25	11.21	0.72	10.02	2.15	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.53	11.81	0.69	7.55	3.71	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	4.93	8.62	1.54	5.24	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.49	11.53	0.94	6.86	2.81	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	3.48	12.99	1.28	8.05	2.74	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	2.96	10.20	0.99	8.23	2.30	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.69	9.96	0.29	6.15	1.46	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.48	11.45	1.74	7.47	3.98	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.79	9.70	1.45	4.85	2.91	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	3.23	8.62	1.35	5.39	1.89	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.72	9.69	1.36	9.08	3.18	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.18	8.29	1.04	4.15	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	3.56	9.42	0.63	7.75	1.68	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	5.86	8.57	1.65	7.22	2.26	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	2.75	4.82	0.00	6.19	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	4.89	6.40	1.88	6.96	1.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.88	7.42	1.38	4.88	2.12	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.88	6.78	0.48	4.36	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.97	7.61	0.33	3.97	1.98	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.32	9.66	2.23	5.82	2.85	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.18	12.22	1.85	7.77	1.85	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.21	7.66	1.48	6.92	2.96	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.71	7.97	1.37	4.67	2.61	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.11	9.01	0.96	7.08	2.25	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	3.65	5.78	1.83	6.70	2.13	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	4.90	10.22	1.54	5.04	3.08	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.40	8.53	1.07	3.91	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.36	4.85	0.48	6.30	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.45	6.22	1.24	5.60	2.96	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	2.51	8.95	1.43	6.45	2.86	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.86	6.86	0.65	7.51	1.96	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.71	10.83	1.18	7.06	2.35	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	5.45	11.88	2.23	6.93	3.84	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.10	5.89	0.00	6.66	1.54	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4.18	9.55	0.60	4.18	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	31.72	9.06	6.80	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	11.51	21.48	7.67	7.67	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	15.59	16.33	5.94	6.68	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	16.93	22.00	6.77	4.65	2.12	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.18	14.77	6.33	8.44	2.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.01	14.01	5.60	5.60	0.93	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	19.58	9.79	6.18	6.18	1.55	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	13.08	10.71	2.38	4.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.17	21.04	5.65	4.75	1.58	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.12	20.65	7.27	4.36	1.45	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	19.81	16.66	8.10	4.50	1.80	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	18.70	21.00	7.99	6.37	2.57	1.49
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	13.87	17.97	5.14	8.73	1.54	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	14.82	14.47	4.23	5.29	2.82	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.99	16.66	1.33	4.00	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.23	19.36	6.11	6.11	1.53	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	15.21	16.01	7.20	5.87	1.33	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	14.36	16.44	6.24	6.61	0.76	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.95	23.32	5.52	5.52	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	12.23	16.31	1.63	4.89	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.45	16.24	6.04	4.79	1.87	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.73	17.38	6.45	3.64	1.68	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	17.52	17.52	10.30	8.24	4.12	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	16.55	14.81	4.35	6.39	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	13.15	17.64	6.28	7.17	1.49	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.28	8.30	5.53	7.75	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.03	16.97	7.07	5.66	2.12	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	16.23	18.07	5.53	5.53	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	16.12	2.30	3.45	1.15	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.82	15.73	4.99	6.91	1.15	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	15.85	15.29	9.62	4.53	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	24.61	14.77	8.20	6.56	3.28	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.56	16.72	4.52	5.42	2.71	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.24	17.24	6.46	6.46	1.44	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	14.19	11.95	2.99	5.23	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	14.12	18.95	4.83	5.95	2.23	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.95	14.21	5.60	4.74	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	14.56	15.41	5.99	4.28	3.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.66	12.66	6.00	7.33	1.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.08	20.51	5.43	6.03	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.93	14.22	7.11	2.13	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	13.75	13.40	7.91	5.16	1.03	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	14.49	16.64	7.51	2.15	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	16.83	16.16	5.39	6.06	2.69	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	17.04	17.04	7.04	4.44	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	22.10	6.98	5.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	10.58	16.92	6.35	5.29	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	12.00	15.61	6.40	6.80	3.20	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	12.36	26.89	6.54	2.18	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.93	16.86	9.20	9.20	2.30	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	11.35	13.81	6.41	6.91	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	10.35	18.82	7.53	9.41	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	13.07	16.59	8.05	8.55	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	17.12	21.18	2.25	6.76	1.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	12.05	8.61	10.33	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	12.91	17.37	7.13	4.90	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.03	15.64	3.91	10.17	1.17	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.85	13.19	7.26	9.24	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	20.24	19.20	5.19	8.30	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.25	24.50	5.69	7.44	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	15.65	17.33	6.71	7.83	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	17.22	16.34	7.51	9.27	1.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	16.97	16.97	6.17	6.94	1.93	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.66	18.23	5.06	7.60	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	13.46	17.30	5.77	5.77	2.40	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	17.09	15.90	5.96	7.55	0.80	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.84	12.15	8.51	6.08	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.91	17.29	6.92	4.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	18.24	13.30	5.32	5.32	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	18.07	14.98	5.16	8.78	2.07	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	16.93	18.14	5.44	5.44	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	15.21	19.01	4.75	6.34	0.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	18.13	20.26	5.86	6.93	2.13	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.84	16.09	5.75	2.87	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	13.37	16.46	4.11	7.71	2.06	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.27	19.10	3.54	8.49	2.83	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	23.27	16.46	7.38	6.81	0.00	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	14.14	16.64	7.49	8.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.14	17.23	8.61	5.48	5.48	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	14.61	14.20	4.18	5.43	1.25	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	16.73	13.47	5.58	8.83	2.32	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.71	21.41	8.70	4.68	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	18.71	11.76	5.35	8.55	1.07	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.78	13.34	5.25	9.70	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.93	9.18	8.26	6.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	20.45	18.67	4.45	2.67	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	15.39	15.96	3.42	5.13	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	18.41	8.44	4.60	6.14	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	17.51	12.59	8.21	4.38	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.92	11.58	1.34	6.68	1.34	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	15.34	11.44	8.06	6.76	2.08	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.22	15.25	7.29	4.64	0.66	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	6.24	2.08	6.24	0.00	4.16
Macrophage - monocyte derived, donor1	11232-116C8	17.09	11.17	1.60	3.42	3.19	0.23
Macrophage - monocyte derived, donor2	11313-117C8	9.36	10.83	1.84	1.65	1.10	0.00
Macrophage - monocyte derived, donor3	11389-118C3	9.18	4.59	1.18	3.28	1.44	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	8.50	14.34	3.72	4.78	2.66	0.53
Mallassez-derived cells, donor2	11929-125I3	9.98	16.64	1.90	7.76	2.85	0.00
Mallassez-derived cells, donor3	11930-125I4	13.48	15.98	1.95	4.86	2.78	0.28
Mammary Epithelial Cell, donor1	11273-116H4	15.74	17.34	3.99	3.19	3.39	0.60
Mammary Epithelial Cell, donor2	11350-117G9	10.13	11.58	3.76	2.90	1.74	0.29
Mammary Epithelial Cell, donor3	11422-118F9	4.99	9.73	1.50	2.49	2.00	0.00
Mast cell - stimulated, donor1	11487-119E2	2.71	10.85	0.00	5.42	2.71	0.00
Mast cell, donor1	11563-120D6	8.98	14.27	2.49	7.68	3.35	0.11
Mast cell, donor2	11565-120D8	2.08	8.92	1.19	3.57	0.89	0.00
Mast cell, donor3	11566-120D9	4.28	9.46	1.13	2.93	1.80	0.00
Mast cell, donor4	11567-120E1	1.60	7.09	1.42	2.84	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	1.11	15.75	1.66	4.99	1.77	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	2.33	7.00	0.58	1.75	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	5.39	19.27	4.02	11.59	5.28	0.46
Mast cell, expanded, donor8	11941-126A6	3.51	20.25	3.85	5.86	3.85	0.00
Melanocyte - dark, donor1	11502-119F8	10.45	18.01	3.78	5.27	7.16	0.10
Melanocyte - dark, donor2	11582-120F7	12.81	9.69	4.50	0.69	3.11	0.35
Melanocyte - dark, donor3	11663-122F7	7.17	17.10	3.91	2.03	2.03	0.07
Melanocyte - light, donor1	11274-116H5	5.17	7.76	1.18	1.18	1.18	0.00
Melanocyte - light, donor2	11351-117H1	13.65	8.19	2.05	2.05	0.68	1.36
Melanocyte - light, donor3	11423-118G1	6.07	0.87	0.00	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	4.79	7.71	2.39	1.56	2.19	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	11.30	11.56	3.50	1.88	2.96	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	8.57	9.91	4.82	0.54	1.34	0.00
Meningeal Cells, donor1	11493-119E8	7.57	13.27	3.10	2.98	0.50	0.12
Meningeal Cells, donor2	11573-120E7	5.28	9.68	3.08	2.64	0.00	0.00
Meningeal Cells, donor3	11654-122E7	7.42	12.39	5.13	2.93	2.61	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.67	12.83	9.70	5.99	4.56	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.86	7.75	2.31	4.33	1.71	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	2.63	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	5.23	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	8.61	9.33	4.31	5.74	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	11.44	8.47	1.48	1.69	0.64	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	7.54	7.04	0.00	2.51	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	9.01	6.59	3.08	3.74	1.54	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	8.04	0.73	2.19	4.38	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.12	6.55	2.66	2.86	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	32.13	14.40	3.88	1.66	0.69	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.72	6.69	1.12	0.74	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	21.84	12.89	4.47	0.92	1.32	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.68	3.26	1.19	0.59	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	4.67	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.89	4.48	1.28	3.20	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	12.76	15.95	3.19	6.03	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.14	12.20	5.63	1.25	0.94	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.06	10.89	4.35	10.16	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	6.89	10.08	3.98	8.49	2.39	0.53
Mesothelial Cells, donor2	12156-128G5	7.01	6.01	2.50	5.00	2.50	0.00
Mesothelial Cells, donor3	11402-118D7	4.12	7.44	2.02	6.36	1.08	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	0.00	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.82	8.37	1.97	2.96	1.23	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.60	8.83	2.36	3.24	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	6.51	6.20	1.24	1.86	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	8.92	4.36	1.66	1.87	1.87	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	11.26	4.25	1.50	2.00	1.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	2.79	3.72	0.00	4.19	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	7.52	8.33	1.42	1.22	0.61	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6.34	5.15	0.40	3.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	8.55	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	14.16	10.62	0.88	2.65	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.22	8.74	3.42	4.56	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	1.32	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.61	5.73	1.49	1.91	1.70	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	1.84	0.92	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	5.66	4.47	1.19	0.89	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	1.68	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.54	4.01	2.01	1.76	1.51	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.80	4.75	0.71	2.85	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	0.00	0.00	1.11	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.22	5.07	1.38	1.15	1.15	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.89	5.05	1.26	1.47	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.30	1.83	0.41	0.82	1.22	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	7.94	6.01	0.86	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.89	2.89	0.44	2.00	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	4.82	1.31	0.44	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.03	0.00	0.51	2.53	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	1.66	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2.45	2.72	0.54	0.82	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.65	4.12	1.18	2.35	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.92	2.88	0.48	0.96	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.60	4.00	2.40	3.20	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	1.37	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	3.50	2.00	1.00	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2.63	2.19	0.88	1.31	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.28	1.28	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	3.22	3.72	1.24	1.49	0.99	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1.39	0.00	0.00	2.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3.76	2.74	0.00	2.39	1.03	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	2.19	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.71	0.71	0.00	1.07	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	2.24	3.37	1.68	1.68	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.66	1.66	0.42	3.33	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.58	0.00	2.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	1.81	3.02	0.00	1.81	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	3.76	2.92	0.42	1.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	2.77	1.85	0.92	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	2.28	2.28	0.00	2.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	2.90	0.97	0.14	1.11	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.15	3.37	0.26	1.81	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.86	1.72	0.43	2.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	2.54	1.91	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	2.14	1.60	0.00	0.80	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	6.88	4.49	1.50	4.79	0.90	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	3.25	2.26	0.28	0.71	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.73	6.05	0.64	1.27	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	5.31	2.21	0.44	2.21	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	3.41	0.38	0.76	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.11	1.99	0.28	1.42	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	9.09	3.93	0.74	3.20	1.23	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.21	1.96	0.00	3.26	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	2.94	4.12	1.18	1.76	1.76	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	12.97	4.04	0.29	2.88	0.86	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	16.49	3.30	0.82	0.82	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	4.76	1.19	0.89	1.79	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	15.07	0.00	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	16.04	1.78	1.78	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	19.39	9.20	1.31	1.97	2.96	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	13.68	6.31	0.00	2.10	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	25.50	11.27	1.58	1.78	1.58	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	21.42	3.73	0.00	1.86	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	16.15	6.01	0.38	1.88	1.88	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.46	6.92	2.13	2.66	1.60	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.72	9.16	2.49	2.04	2.49	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.05	4.42	1.47	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.95	4.03	2.20	0.37	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	6.22	0.00	1.56	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.69	3.21	0.53	1.07	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	3.86	3.86	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	5.05	1.01	2.02	3.03	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.17	1.69	1.69	1.26	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	2.72	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	3.26	6.52	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	7.11	12.71	1.51	5.60	1.94	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	10.45	9.93	1.05	1.57	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.00	4.67	1.33	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	1.25	1.67	0.83	1.25	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	6.85	9.70	2.09	4.18	2.09	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	1.60	6.38	0.00	3.19	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	1.36	2.72	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	1.84	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	2.93	7.12	1.67	1.26	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	4.88	9.30	1.86	2.09	2.09	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.32	7.03	1.62	1.62	1.62	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	7.15	4.63	1.68	2.31	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	2.98	7.94	1.99	1.99	1.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.01	8.39	3.79	2.17	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.48	10.65	1.59	2.95	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	4.57	3.76	1.63	1.63	0.65	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	8.57	5.65	2.00	1.64	1.46	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	9.55	4.24	1.06	3.71	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.60	4.80	1.20	0.60	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	11.81	9.85	3.28	2.95	1.97	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.16	4.07	0.81	1.79	1.14	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	7.06	1.76	1.76	1.76	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	2.81	0.70	2.81	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.27	4.14	3.22	2.30	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.32	7.07	2.25	1.29	1.29	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	15.52	5.17	2.07	4.14	2.41	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	5.06	0.00	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	6.24	4.01	0.89	0.89	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.93	5.93	1.69	1.27	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	5.70	5.93	1.19	2.14	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	7.30	5.58	2.15	1.29	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	18.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.66	3.67	2.33	1.67	2.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	0.90	2.25	0.90	0.90	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.76	5.56	2.78	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	11.14	3.71	0.93	1.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	10.97	3.41	3.41	2.65	1.89	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.50	4.56	0.98	2.61	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	5.67	3.49	3.05	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	5.43	2.71	0.90	0.90	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	3.53	3.53	3.53	0.88	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	4.65	1.33	2.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	3.97	4.96	2.98	3.47	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	2.68	2.68	0.77	0.38	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	15.42	6.65	4.54	3.33	1.21	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	5.75	4.42	2.65	1.77	0.88	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.71	4.07	2.71	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	5.11	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	8.54	4.27	1.83	3.05	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	3.78	3.46	0.94	2.20	1.26	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.66	2.12	0.61	0.91	0.91	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	4.75	3.16	0.79	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	5.67	5.67	2.27	4.53	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	8.70	12.30	1.99	4.97	2.61	0.12
Myoblast, donor2	11322-117D8	9.01	9.40	2.88	3.26	2.69	0.38
Myoblast, donor3	11398-118D3	6.89	11.27	2.69	3.87	2.19	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	18.97	10.36	8.32	0.88	2.33	0.15
Natural Killer Cells, donor1	11230-116C6	5.54	15.07	1.85	4.61	1.54	0.00
Natural Killer Cells, donor2	11311-117C6	3.02	11.76	0.90	2.71	1.21	0.00
Natural Killer Cells, donor3	11387-118C1	4.23	8.83	1.47	4.79	1.47	0.18
Neural stem cells, donor1	11275-116H6	11.25	13.07	5.81	3.99	1.45	0.00
Neural stem cells, donor2	11352-117H2	5.78	11.55	5.78	0.00	0.00	1.93
Neurons, donor1	11494-119E9	10.24	5.69	6.83	1.14	2.28	1.14
Neurons, donor2	11574-120E8	9.47	11.89	8.15	1.76	1.54	1.10
Neurons, donor3	11655-122E8	9.04	8.22	3.29	4.11	0.82	0.00
Neutrophils, donor1	11233-116C9	2.78	9.28	0.00	102.08	3.71	0.00
Neutrophils, donor2	11314-117C9	0.00	8.70	0.00	55.08	2.90	0.00
Neutrophils, donor3	11390-118C4	3.05	3.67	0.00	161.87	2.44	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	34.67	11.64	8.67	3.21	2.26	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	22.79	10.09	4.23	1.95	1.63	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	19.25	7.22	2.81	2.01	0.60	0.20
Olfactory epithelial cells, donor1	11933-125I7	7.16	5.78	2.20	1.51	0.96	0.00
Olfactory epithelial cells, donor2	11934-125I8	9.99	6.80	1.45	1.30	1.45	0.14
Olfactory epithelial cells, donor3	11935-125I9	12.15	8.29	3.86	1.14	1.02	0.11
Olfactory epithelial cells, donor4	11936-126A1	10.42	8.86	4.19	0.78	1.17	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	13.24	13.24	3.61	6.02	2.41	0.00
Osteoblast - differentiated, donor1	11276-116H7	13.40	5.53	1.49	1.49	0.85	0.00
Osteoblast - differentiated, donor2	11353-117H3	27.43	4.57	1.14	4.57	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.24	4.34	1.86	1.86	0.62	0.62
Osteoblast, donor1	11277-116H8	16.22	12.12	4.50	1.56	1.95	0.39
Osteoblast, donor2	11354-117H4	11.24	7.02	1.40	2.81	1.40	0.00
Osteoblast, donor3	11426-118G4	7.64	6.22	3.55	4.27	0.89	0.18
Pancreatic stromal cells, donor1	11249-116E7	13.48	9.86	5.73	2.36	2.02	0.51
Pericytes, donor1	11491-119E6	4.34	4.23	1.56	0.67	0.11	0.00
Pericytes, donor2	11571-120E5	2.72	4.07	1.13	0.00	0.68	0.00
Pericytes, donor3	11652-122E5	5.70	9.36	1.83	3.05	1.02	0.00
Perineurial Cells, donor1	11499-119F5	9.38	10.28	3.28	2.94	1.36	0.11
Perineurial Cells, donor2	11579-120F4	18.31	8.93	4.78	2.39	2.21	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	12.11	14.34	2.87	3.82	1.59	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	6.61	6.61	0.49	4.90	1.71	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	5.69	8.41	1.04	2.46	2.33	0.00
Placental Epithelial Cells, donor1	11278-116H9	9.09	8.37	5.50	6.94	1.91	0.24
Placental Epithelial Cells, donor2	11355-117H5	24.40	13.31	4.44	4.44	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	26.11	9.03	5.89	1.18	2.16	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	4.43	6.01	2.53	1.90	1.27	0.00
Preadipocyte - breast, donor1	11467-119B9	9.94	10.50	2.44	2.06	1.50	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	7.96	18.40	2.74	5.48	2.74	0.13
Preadipocyte - breast, donor2	11328-117E5	7.43	6.75	2.03	4.05	1.58	0.00
Preadipocyte - omental, donor1	11468-119C1	11.61	11.72	2.88	1.92	1.39	0.32
Preadipocyte - omental, donor2	11329-117E6	7.86	12.22	2.62	2.62	2.18	0.44
Preadipocyte - omental, donor3	11403-118D8	5.44	7.88	2.15	3.87	1.72	0.00
Preadipocyte - perirenal, donor1	11469-119C2	16.73	7.87	4.92	3.94	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	9.21	12.90	3.99	5.53	2.15	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	9.03	8.32	4.25	3.36	0.35	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	6.98	8.68	2.55	2.89	0.85	0.00
Preadipocyte - visceral, donor1	11280-116I2	11.08	13.13	4.01	3.45	1.40	0.09
Preadipocyte - visceral, donor2	11357-117H7	5.06	6.90	1.84	2.76	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	7.63	9.09	3.34	1.67	0.73	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	22.48	8.45	6.94	1.81	1.51	0.30
Prostate Epithelial Cells, donor2	11331-117E8	4.74	7.85	1.49	4.87	1.62	0.00
Prostate Epithelial Cells, donor3	11404-118D9	5.14	3.43	1.10	2.33	1.47	0.00
Prostate Stromal Cells, donor1	11254-116F3	10.93	9.45	3.42	5.81	2.05	0.11
Prostate Stromal Cells, donor2	11332-117E9	7.71	9.32	1.97	4.48	1.26	0.18
Prostate Stromal Cells, donor3	11405-118E1	11.68	7.92	3.13	2.82	1.04	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	3.65	10.95	2.55	2.92	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	7.69	12.89	3.81	4.23	1.94	0.62
Renal Epithelial Cells, donor1	11517-119H5	1.52	3.04	1.01	1.01	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	4.98	10.67	2.13	2.85	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	9.53	13.13	4.45	2.75	1.27	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	3.40	0.68	0.68	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	4.85	8.76	1.62	4.18	1.62	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	4.22	10.21	2.00	3.33	1.33	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	0.00	0.00	2.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	7.26	8.80	2.20	2.20	0.88	0.66
Renal Mesangial Cells, donor2	11598-120H5	4.39	9.40	5.02	0.00	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.50	4.99	2.50	0.00	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	9.93	8.59	2.95	4.83	2.15	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.11	5.90	0.84	1.69	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	6.56	8.10	3.66	2.12	0.77	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	15.04	19.96	9.59	2.85	3.11	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	19.61	13.93	6.25	2.56	0.28	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	3.09	2.06	1.03	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.58	9.79	3.76	2.51	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	14.43	13.50	9.35	6.15	1.60	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	7.15	8.93	8.93	3.57	3.57	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	22.57	22.01	15.96	5.50	6.60	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	15.66	9.86	5.80	2.32	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	12.48	13.26	4.94	2.47	1.95	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	8.74	12.31	5.16	3.97	1.69	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	16.51	20.19	9.26	7.70	4.24	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	17.24	17.99	8.81	4.71	2.73	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	9.09	11.19	6.64	4.89	2.56	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	14.10	13.41	9.25	4.85	1.85	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	9.45	9.99	4.93	3.56	1.37	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	9.38	11.35	3.93	4.08	1.51	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	15.95	13.26	9.14	5.91	3.58	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	13.05	15.49	8.18	4.16	0.57	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	8.91	11.80	6.01	5.37	1.93	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	12.39	10.18	5.97	5.09	2.66	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	10.71	12.24	5.54	2.29	1.53	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	6.06	9.41	4.66	4.29	1.86	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	15.22	19.35	8.64	5.07	3.57	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	7.70	9.16	5.18	4.91	0.93	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	9.05	7.59	4.96	5.94	1.85	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	13.56	16.61	8.02	6.30	2.10	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	8.65	12.92	5.45	3.63	1.07	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	7.85	11.49	5.89	5.05	2.80	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	10.08	12.48	5.81	4.79	2.39	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	9.85	11.85	5.83	3.65	0.73	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	8.71	10.55	5.40	4.78	2.21	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	12.09	12.89	6.98	4.43	1.88	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	12.27	20.05	9.91	2.83	0.71	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	8.53	11.90	7.14	3.97	4.37	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	14.73	13.80	7.72	5.61	2.10	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	13.06	16.38	6.22	4.56	1.87	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	8.63	14.16	6.19	5.31	2.21	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	9.19	10.44	6.48	4.39	1.88	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	14.27	12.79	8.08	2.96	2.29	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	6.47	11.07	4.43	3.92	2.04	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	7.13	14.65	5.01	4.05	2.12	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	20.29	17.54	13.07	4.47	0.69	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	7.54	10.01	6.31	4.66	2.61	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	14.45	14.45	8.54	2.96	3.28	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	18.92	11.42	9.37	3.92	0.85	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	12.58	12.72	9.03	5.62	2.07	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	11.20	13.33	7.20	5.06	1.07	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	22.54	11.75	8.16	4.01	1.24	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	15.95	11.91	7.14	6.67	2.62	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	15.72	10.68	6.05	5.84	3.02	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	29.01	12.05	9.23	3.77	1.41	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	24.46	10.83	7.69	3.84	4.54	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	13.30	11.48	5.14	6.95	3.93	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	21.91	13.95	8.44	4.77	0.73	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	35.08	24.45	12.52	10.04	5.53	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	23.73	9.73	12.78	5.48	5.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	23.81	16.28	11.15	4.52	1.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	26.01	12.67	10.40	7.92	4.07	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	24.86	12.28	8.39	2.40	3.59	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	29.64	16.06	7.20	6.14	1.42	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	27.53	11.31	11.10	4.06	3.63	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	27.04	12.62	7.21	7.21	7.81	0.60
Schwann Cells, donor1	11498-119F4	3.20	4.89	2.44	0.94	0.75	0.94
Schwann Cells, donor2	11578-120F3	3.40	6.80	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	6.57	10.30	3.72	2.19	1.10	0.44
Sebocyte, donor1	11220-116B5	12.60	10.96	2.19	0.55	2.74	0.55
Sebocyte, donor2	11301-117B5	8.73	7.35	1.84	0.46	2.30	0.00
Sebocyte, donor3	11378-118B1	12.16	4.74	1.65	0.82	1.24	0.41
Sertoli Cells, donor1	11255-116F4	8.28	4.97	0.00	4.97	4.97	1.66
Sertoli Cells, donor2	11333-117F1	5.65	2.82	5.65	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	26.31	10.03	5.37	4.22	0.88	0.53
Skeletal Muscle Cells, donor2	11358-117H8	7.23	0.72	2.89	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	7.52	6.69	5.02	5.02	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	11.94	10.68	4.56	3.77	1.10	0.31
Skeletal Muscle Cells, donor5	11455-119A6	12.04	7.28	3.72	2.68	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	10.47	12.47	4.77	3.69	0.31	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	34.02	16.76	9.83	2.65	2.02	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	18.55	10.56	6.99	3.14	1.00	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	11.81	9.03	5.16	4.27	1.09	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	11.88	10.78	3.88	3.62	0.76	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	11.58	7.24	4.34	2.17	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.02	7.57	2.61	1.79	0.83	0.28
Skin - palm, donor1	10286-104F7	0.00	2.69	0.00	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.19	6.34	1.01	0.86	1.59	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	21.27	36.81	7.36	3.27	6.54	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	7.40	5.45	1.82	0.39	0.78	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	10.29	8.62	2.36	1.95	3.06	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	7.03	4.08	1.27	0.56	1.13	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	12.26	25.16	3.81	4.23	5.50	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	2.77	3.67	0.97	1.20	1.57	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.80	6.17	2.78	4.01	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.45	11.12	1.33	3.56	1.56	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.34	10.58	2.35	1.18	2.35	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.07	6.85	2.21	3.54	1.10	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	8.27	9.06	1.97	3.15	2.76	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.04	9.27	1.55	0.77	3.86	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	22.02	4.00	3.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	9.18	9.85	2.79	4.13	2.93	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	15.96	10.20	3.32	3.99	0.89	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.71	8.32	2.56	6.27	1.92	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.44	9.77	5.21	1.30	0.98	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	11.81	8.56	4.13	1.48	0.89	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	5.84	6.12	1.14	2.70	1.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.39	4.23	1.14	1.14	1.14	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.35	6.39	1.22	0.61	1.22	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	17.43	10.10	2.27	2.27	0.76	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.15	9.06	1.91	3.81	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	17.55	8.41	3.24	2.21	1.77	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	14.21	5.17	3.87	1.72	1.08	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.11	8.50	3.99	2.73	1.47	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7.73	8.66	2.63	4.33	3.40	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	9.70	3.23	4.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.17	8.07	3.89	2.09	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.83	7.51	3.41	2.73	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	46.02	12.33	10.21	0.86	1.33	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.86	8.76	3.72	3.22	1.11	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	10.24	6.14	1.37	2.05	1.59	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	14.49	10.87	3.02	1.81	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	13.25	9.27	2.65	2.38	2.12	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	17.31	12.12	3.06	1.73	1.07	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.02	7.01	2.38	2.25	1.50	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	11.16	6.34	2.79	2.03	1.01	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	8.44	8.14	2.26	3.17	1.96	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.00	4.50	2.25	1.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	0.00	6.46	1.29	1.29	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	9.77	6.51	1.86	4.65	1.86	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.08	8.58	4.54	5.55	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.78	7.52	2.82	4.39	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	8.55	6.49	2.36	1.77	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	11.33	10.00	4.50	3.25	1.50	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	16.35	6.54	3.27	3.74	1.40	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.35	10.22	2.30	5.47	3.17	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	7.39	8.67	2.04	5.61	2.29	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.45	5.64	2.44	2.26	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	8.94	11.04	2.93	1.96	1.96	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.32	6.95	3.02	2.18	1.17	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	0.48	0.48	1.43	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.85	9.05	2.45	3.43	3.18	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	10.83	10.61	1.33	2.43	0.88	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	7.02	8.19	3.80	0.88	0.59	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.61	2.33	2.33	1.36	1.55	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	4.50	2.38	1.06	2.38	1.06	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.97	6.32	3.35	3.35	1.49	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.62	7.19	2.16	3.23	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	5.39	8.23	1.42	2.84	1.70	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.24	8.27	3.15	3.15	0.39	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	12.44	3.81	3.30	1.52	1.52	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	21.16	3.99	6.39	1.20	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	11.70	2.93	2.93	1.67	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	20.17	6.88	5.50	1.83	0.46	0.46
Synoviocyte, donor1	11291-117A4	9.93	7.24	3.70	3.03	1.35	0.17
Synoviocyte, donor2	11368-117I9	15.42	11.06	3.52	5.36	2.35	0.00
Synoviocyte, donor3	11440-118H9	15.64	9.38	1.34	2.23	0.67	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	8.58	5.36	4.29	2.86	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	3.70	2.78	1.85	1.39	1.62	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	16.85	10.04	4.09	1.65	1.79	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	10.05	6.96	2.71	1.16	1.93	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.16	9.74	2.29	1.15	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	15.26	15.13	6.40	4.92	2.34	0.49
Urethra, donor2	10319-105A4	1.80	7.19	1.80	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	6.91	8.77	0.80	1.06	2.39	0.00
Urothelial Cells, donor2	11600-120H7	4.01	6.41	1.20	1.60	0.80	0.00
Urothelial Cells, donor3	11681-122H7	5.04	6.65	0.69	1.38	1.60	0.00
Urothelial cells, donor0	11216-116B1	14.27	15.16	3.79	1.56	2.67	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	13.35	28.47	1.78	31.14	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	12.87	24.30	10.01	35.74	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	6.85	15.06	3.42	31.49	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	7.23	33.06	2.41	26.17	3.79	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	10.46	24.40	4.07	38.93	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	6.25	20.82	5.21	40.61	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	7.34	35.79	1.84	16.52	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	7.30	21.91	1.83	30.13	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	19.12	6.17	6.54	3.45	0.86	0.86
Wilms' tumor cell line:HFWT	10597-108E3	5.28	4.40	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	9.50	9.78	1.96	1.96	1.12	0.00
achilles tendon, donor2	10292-104G4	0.00	2.07	2.07	8.27	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	13.51	14.79	6.88	3.31	2.29	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	4.18	30.65	0.46	5.11	4.41	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	8.67	12.46	4.51	17.57	1.90	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	14.97	25.31	4.63	14.97	3.54	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	12.93	20.52	3.09	8.43	3.65	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	25.59	10.15	3.38	11.00	2.75	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	24.23	6.26	2.72	8.71	1.36	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	42.30	10.58	2.64	2.64	3.97	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	34.30	13.07	2.86	4.08	2.86	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	22.13	20.19	3.11	5.05	5.82	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	19.32	6.81	1.84	6.44	1.29	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	7.80	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	32.07	11.15	4.65	6.04	3.25	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	21.23	11.91	4.92	11.91	2.07	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	14.90	11.69	2.34	8.18	1.17	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	13.48	5.58	0.93	1.86	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	9.87	6.99	0.00	6.58	4.11	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	3.38	4.30	0.31	5.22	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	13.65	14.08	1.71	6.40	2.13	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	18.20	18.50	3.34	3.64	2.12	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	18.53	11.79	2.65	6.26	2.17	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	12.70	5.35	2.23	4.45	2.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	3.00	7.67	2.67	5.34	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	3.72	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1.88	6.78	1.51	6.78	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	6.98	11.34	0.87	0.87	3.05	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	3.75	9.37	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	12.01	7.30	5.65	7.54	1.88	0.24
adipose tissue, adult, pool1	10010-101C1	9.46	9.15	0.93	5.43	1.86	0.00
adipose, donor1	10184-103D4	68.61	14.66	15.83	5.28	2.93	0.59
adipose, donor2	10185-103D5	19.87	8.92	4.06	0.81	0.41	0.81
adipose, donor3	10186-103D6	16.88	8.17	7.62	3.81	1.63	1.09
adipose, donor4	10187-103D7	21.67	6.93	5.20	5.20	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	6.00	5.05	3.63	0.63	0.47	0.47
adrenal gland, adult, pool1	10081-102A9	7.28	14.55	7.28	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	20.68	11.61	5.87	0.93	1.33	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	5.00	8.93	4.64	2.86	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	7.65	12.98	2.32	4.64	1.85	0.23
amniotic membrane cells, donor2	12236-129G4	24.68	18.60	9.47	1.69	3.38	0.34
amniotic membrane cells, donor3	12237-129G5	12.37	9.13	2.65	2.06	1.18	0.29
amygdala - adult, donor10196	10167-103B5	5.93	21.34	11.86	3.56	5.93	0.00
amygdala, adult, donor10252	10151-102I7	10.14	11.15	10.75	2.23	1.82	1.01
amygdala, newborn, donor10223	10360-105E9	4.52	8.39	7.10	3.87	1.61	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	26.36	15.15	7.64	1.78	4.84	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	5.29	7.94	3.31	20.08	1.54	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	17.37	9.02	9.02	0.00	2.34	1.00
aorta, adult, pool1	10052-101G7	11.18	7.85	2.35	1.57	0.59	0.39
appendix, adult	10189-103D9	6.60	11.64	3.10	3.49	4.27	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	6.53	19.26	3.78	2.41	0.34	0.34
artery, adult	10190-103E1	9.51	8.15	1.36	2.72	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	38.68	16.51	12.17	2.75	1.59	1.16
b cell line:RPMI1788	10427-106D4	11.60	10.71	6.39	1.93	1.34	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	3.33	7.77	0.28	4.16	3.61	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	8.53	4.37	1.49	6.35	1.49	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	5.69	4.35	2.18	33.48	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	24.61	12.30	0.56	2.24	2.24	0.00
bladder, adult, pool1	10011-101C2	10.10	11.52	3.15	2.93	1.30	0.11
blood, adult, pool1	10053-101G8	4.43	13.29	2.21	6.64	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	5.99	5.99	0.00	3.43	0.00	0.00
bone marrow, adult	10192-103E3	13.50	8.77	4.05	2.70	0.00	0.00
brain, adult, donor1	10084-102B3	8.20	16.40	12.30	1.03	7.18	1.03
brain, adult, pool1	10012-101C3	10.80	17.59	10.13	1.22	0.89	1.45
brain, fetal, pool1	10085-102B4	8.01	8.01	8.01	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	7.93	9.91	1.32	3.96	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	9.24	12.98	4.99	3.50	2.62	0.37
breast, adult, donor1	10080-102A8	9.47	11.36	1.89	6.94	3.79	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	12.70	13.08	7.37	1.14	1.78	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	12.99	6.18	8.35	4.02	0.93	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	20.03	34.07	12.89	3.45	2.76	2.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	1.94	8.47	2.91	6.05	0.97	0.48
carcinoid cell line:NCI-H1770	10703-109H1	5.64	7.52	3.29	3.76	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	3.17	5.47	0.88	1.20	0.55	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	14.58	7.92	4.44	3.17	1.27	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	9.85	7.99	4.26	9.85	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	9.21	13.82	10.36	1.15	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	10.04	15.90	9.87	2.18	2.18	1.34
caudate nucleus, adult, donor10258	10379-105H1	8.41	25.22	9.17	2.29	4.58	0.76
caudate nucleus, newborn, donor10223	10354-105E3	10.62	15.75	12.09	3.30	1.10	1.10
cerebellum - adult, donor10196	10173-103C2	11.65	2.91	8.74	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	7.90	13.45	11.10	4.27	2.14	0.43
cerebellum, adult, pool1	10083-102B2	5.86	11.73	6.21	1.38	1.03	0.34
cerebellum, newborn, donor10223	10357-105E6	5.81	19.93	14.11	8.30	1.66	2.49
cerebral meninges, adult	10188-103D8	9.83	15.88	9.58	1.51	0.76	0.76
cerebrospinal fluid, donor2	10294-104G6	7.31	2.92	2.19	1.46	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	24.87	19.27	7.48	12.94	1.73	0.43
cervical cancer cell line:ME-180	10553-107I4	24.03	14.58	7.29	0.99	2.98	0.00
cervix, adult, pool1	10013-101C4	14.38	11.44	4.41	2.83	1.05	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	14.63	9.34	4.60	3.20	1.81	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	0.00	2.61	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	32.44	11.31	6.21	2.24	1.86	0.62
choriocarcinoma cell line:SCH	10785-110H2	38.20	8.01	9.12	6.65	1.36	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	4.03	3.32	1.66	2.37	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	11.11	12.82	3.99	6.27	2.56	0.85
chorionic membrane cells, donor2	12239-129G7	11.04	10.64	3.78	4.47	2.19	0.20
chorionic membrane cells, donor3	12240-129G8	11.54	14.84	6.04	2.20	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	18.18	3.03	7.07	4.04	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	4.23	9.99	0.58	3.65	3.65	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	5.28	8.03	1.90	2.96	1.06	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	4.11	5.14	2.31	1.03	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	3.63	6.29	3.14	1.94	0.24	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	4.89	4.89	2.44	2.65	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	4.42	10.01	1.18	2.36	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	13.81	15.12	4.17	5.99	3.39	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.69	11.20	5.03	0.46	1.37	0.00
clear cell carcinoma cell line:TEN	10636-108I6	25.16	12.49	7.63	4.16	1.56	0.69
colon carcinoma cell line:CACO-2	10513-107D9	25.99	6.96	6.41	2.75	1.10	0.73
colon carcinoma cell line:COLO-320	10420-106C6	55.87	18.24	12.92	2.28	2.28	1.14
colon, adult, donor1	10082-102B1	8.33	26.18	5.95	2.38	3.57	0.00
colon, adult, pool1	10014-101C5	6.82	10.22	3.53	6.93	2.23	0.12
colon, fetal, donor1	10070-101I7	4.33	5.56	4.33	3.09	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	4.58	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	6.80	5.52	5.95	3.82	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	12.98	5.74	5.28	3.17	0.91	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	11.56	5.78	7.47	5.22	0.99	0.42
corpus callosum, adult, pool1	10042-101F6	10.28	34.05	8.18	3.43	2.21	1.55
cruciate ligament, donor2	10295-104G7	5.67	1.62	1.62	4.86	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	6.42	4.01	1.61	0.80	0.00	0.00
diencephalon, adult	10193-103E4	7.44	15.36	5.28	1.44	1.92	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	12.63	12.17	4.59	2.76	0.69	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	11.03	8.46	1.54	0.77	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	21.66	5.06	5.06	4.81	1.20	0.48
ductus deferens, adult	10196-103E7	6.98	15.45	6.48	3.99	2.49	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	5.76	11.52	7.20	2.88	7.20	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	9.56	15.45	2.21	6.62	0.00	2.21
dura mater, adult, donor1	10041-101F5	11.89	7.27	1.98	2.73	1.16	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	22.65	4.89	9.77	7.55	0.44	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.48	16.34	10.89	4.87	1.29	2.15
embryonic pancreas cell line:1B2C6	10604-108F1	3.08	1.23	0.00	1.23	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	2.72	3.33	1.21	1.82	1.21	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	4.63	1.85	0.93	1.85	1.54	0.00
embryonic pancreas cell line:2C6	10603-108E9	2.63	2.63	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	13.74	4.02	4.02	1.68	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	9.24	9.42	3.99	1.45	1.63	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	6.43	5.79	5.63	6.91	0.96	0.32
epidermoid carcinoma cell line:A431	10426-106D3	14.34	5.45	4.34	1.78	1.56	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	7.37	7.15	2.20	4.95	1.65	0.00
epididymis, adult	10197-103E8	8.37	15.91	6.49	4.60	1.05	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	1.42	7.27	1.60	1.95	1.24	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	9.04	4.72	1.97	2.75	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	6.55	7.47	1.70	4.98	0.52	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	9.15	11.91	4.04	4.13	0.98	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	5.49	6.83	3.02	5.38	0.22	0.22
esophagus, adult, pool1	10015-101C6	9.45	9.45	2.97	4.03	1.49	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	38.07	7.26	7.89	2.50	0.75	0.50
eye - muscle inferior rectus, donor1	10272-104E2	4.83	9.66	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	4.21	2.10	2.10	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	2.98	4.46	4.46	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	2.29	4.59	1.15	6.88	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	0.00	0.00	1.46	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	8.90	9.41	5.34	5.59	0.76	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	15.39	13.21	6.15	2.44	2.82	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	12.11	9.26	7.36	3.56	2.14	0.95
frontal lobe, adult, pool1	10040-101F4	12.38	22.61	12.67	2.53	1.97	1.31
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	14.11	10.81	6.00	6.91	0.60	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	6.49	11.06	3.47	4.85	2.65	0.37
gall bladder, adult	10198-103E9	7.48	13.28	1.69	6.52	0.72	0.24
gamma delta positive T cells, donor1	11937-126A2	7.52	40.80	5.37	3.22	3.76	0.54
gamma delta positive T cells, donor2	11938-126A3	8.22	31.37	4.11	1.87	3.73	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	10.56	16.69	4.22	2.53	1.48	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	3.87	11.60	1.74	2.13	2.51	0.00
gastric cancer cell line:AZ521	10549-107H9	17.54	13.77	8.85	2.95	1.15	1.80
gastric cancer cell line:GSS	10560-108A2	4.58	8.24	2.75	1.83	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	14.85	16.91	3.66	3.43	2.51	0.91
giant cell carcinoma cell line:LU65	10487-107B1	3.44	4.47	1.95	12.85	0.69	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	12.18	13.16	4.76	5.04	2.52	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	2.99	3.99	2.00	0.50	0.50	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	0.32	6.33	0.32	2.53	1.16	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	0.14	4.07	0.28	1.97	1.40	0.00
glioblastoma cell line:T98G	10485-107A8	8.50	6.07	5.41	0.77	0.77	0.11
glioma cell line:GI-1	10413-106B8	8.20	7.61	2.05	2.93	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	5.83	16.76	5.10	0.73	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	13.43	27.09	7.32	2.69	2.20	0.24
globus pallidus, adult, donor10258	10367-105F7	13.69	28.75	6.85	1.37	4.11	1.37
globus pallidus, newborn, donor10223	10364-105F4	5.86	14.92	6.93	2.66	2.66	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	4.89	4.89	0.00	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	10.93	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	10.45	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	5.44	2.56	2.24	1.92	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	39.02	7.35	9.18	4.59	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	43.44	4.57	3.20	2.29	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	43.15	5.15	1.29	1.93	0.00	0.00
hIPS, biol_rep1	14380-156B6	40.24	4.31	1.44	1.44	0.00	1.44
hIPS, biol_rep2	14381-156B7	43.90	6.86	2.74	2.06	0.69	0.00
hIPS, biol_rep3	14382-156B8	24.28	19.86	7.72	4.41	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	6.03	6.03	4.88	1.15	2.01	0.29
heart - mitral valve, adult	10205-103F7	3.89	8.97	2.39	5.08	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	3.40	9.67	3.14	6.01	1.83	0.26
heart - tricuspid valve, adult	10207-103F9	2.50	6.66	0.00	7.49	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	4.08	6.94	1.84	1.63	1.22	0.20
heart, adult, diseased, donor1	10051-101G6	4.68	5.96	1.70	0.43	0.85	0.85
heart, adult, pool1	10016-101C7	3.68	5.06	3.22	4.14	0.46	0.69
heart, fetal, pool1	10046-101G1	9.55	8.21	4.93	4.93	1.13	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	3.09	4.63	2.16	1.85	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	7.14	0.00	2.38	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	63.65	14.36	23.20	16.35	1.77	2.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	65.91	15.66	26.58	16.26	1.94	2.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	71.65	17.38	24.05	19.30	1.72	1.41
hepatoma cell line:Li-7	10484-107A7	6.12	7.12	3.23	2.67	0.78	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	18.49	7.04	2.71	3.22	1.51	0.70
hippocampus - adult, donor10196	10169-103B7	12.30	17.03	4.73	2.84	3.79	0.95
hippocampus, adult, donor10252	10153-102I9	6.74	16.33	8.37	2.25	1.02	1.22
hippocampus, adult, donor10258	10374-105G5	12.45	18.92	8.47	0.50	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	4.58	10.57	6.34	1.41	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	72.02	12.21	10.38	7.93	3.05	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	33.97	6.68	5.89	3.73	0.79	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	39.10	5.84	6.09	7.11	2.03	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	31.58	7.33	16.35	1.13	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	33.31	7.23	12.39	0.52	1.29	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	40.62	16.32	18.22	3.04	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	18.69	13.72	12.55	3.50	1.75	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	23.48	8.62	9.91	3.45	0.65	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	22.52	7.92	9.59	3.34	0.83	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	28.18	13.02	15.39	3.55	2.13	2.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	18.00	8.52	10.45	4.02	1.45	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	34.34	12.79	5.39	5.39	2.69	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	42.88	5.32	4.38	3.13	0.78	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	49.62	7.37	6.39	3.93	0.98	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	109.09	13.96	15.71	9.60	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	35.70	10.12	13.36	2.67	1.34	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	38.81	8.72	12.21	2.18	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	52.47	11.99	16.49	2.50	1.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	28.45	7.72	7.72	1.32	1.13	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	35.47	7.73	6.37	1.82	0.91	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	27.88	13.16	10.34	4.07	0.63	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	24.33	10.45	11.59	3.76	1.14	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	19.45	13.64	10.16	2.32	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	18.53	5.68	12.55	5.08	0.90	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	36.95	7.76	6.10	4.62	1.11	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	37.09	8.84	6.28	5.14	1.71	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	53.49	13.07	6.94	6.12	1.22	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	29.57	7.75	8.80	2.46	0.00	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	30.41	8.87	10.45	1.90	1.58	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	37.83	8.78	11.80	2.12	1.51	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	17.07	11.89	5.17	2.59	1.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	23.91	5.98	13.28	1.99	0.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	19.24	7.95	8.21	4.10	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	19.17	10.23	8.95	2.56	1.02	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	27.26	13.63	8.33	3.03	3.03	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	25.88	11.76	13.11	6.05	0.34	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	35.50	9.66	9.90	3.86	0.97	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	46.79	8.91	9.36	3.57	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	42.44	9.76	4.88	4.88	1.46	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	32.70	9.78	8.86	2.44	0.61	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	185.43	29.28	55.31	3.25	6.51	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	57.91	14.23	16.55	1.32	1.32	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	33.39	12.04	8.76	3.28	2.74	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	21.35	13.75	11.58	3.62	1.45	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	20.64	9.96	12.81	3.20	1.78	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	11.93	13.13	10.74	4.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	23.83	12.05	12.73	3.66	1.76	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	18.86	10.51	10.24	3.50	1.08	0.00
immature langerhans cells, donor1	11904-125F5	3.87	1.70	0.24	0.97	0.48	0.24
immature langerhans cells, donor2	11905-125F6	0.79	3.96	0.00	4.75	0.79	0.00
insula, adult, pool1	10039-101F3	11.55	24.32	13.25	2.08	3.60	1.51
keratoacanthoma cell line:HKA-1	10791-110H8	14.31	13.66	2.93	1.95	0.65	0.00
kidney, adult, pool1	10017-101C8	14.72	17.92	7.31	4.51	3.20	0.70
kidney, fetal, pool1	10045-101F9	18.96	16.69	9.27	2.90	2.05	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	9.37	14.20	1.70	3.41	2.84	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	13.55	11.06	6.64	2.21	1.11	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	13.95	3.67	2.57	3.12	0.18	0.73
left atrium, adult, donor1	10079-102A7	7.08	4.90	1.09	2.72	0.54	0.00
left ventricle, adult, donor1	10078-102A6	5.06	4.55	0.51	2.02	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	6.02	3.83	1.64	2.19	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	11.14	7.54	2.51	2.87	1.44	0.36
leiomyoma cell line:15242A	10570-108B3	4.35	6.52	2.17	3.26	1.09	0.00
leiomyoma cell line:15425	10571-108B4	5.34	4.61	2.67	4.86	1.46	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	2.09	1.05	0.00	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	10.63	4.37	2.13	3.78	1.30	0.24
liposarcoma cell line:KMLS-1	10782-110G8	6.87	5.94	1.09	1.41	0.94	0.00
liposarcoma cell line:SW 872	10726-110A6	4.87	8.53	3.41	2.68	1.95	0.12
liver, adult, pool1	10018-101C9	11.99	9.24	6.00	5.51	1.30	0.49
liver, fetal, pool1	10086-102B5	6.58	4.70	6.58	3.76	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	5.69	9.92	4.37	1.46	1.02	0.44
locus coeruleus, adult, donor10252	10165-103B3	9.04	18.64	9.04	3.88	2.95	0.74
locus coeruleus, adult, donor10258	10375-105G6	9.59	16.36	8.46	3.39	3.39	1.41
locus coeruleus, newborn, donor10223	10362-105F2	8.41	17.67	7.99	2.94	1.26	1.26
lung adenocarcinoma cell line:A549	10499-107C4	8.44	8.72	2.91	3.88	0.55	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	2.07	4.14	2.07	1.38	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	11.47	8.44	5.01	3.16	0.79	0.13
lung, adult, pool1	10019-101D1	12.29	8.03	3.43	3.78	1.30	0.24
lung, fetal, donor1	10068-101I5	17.12	15.13	8.56	2.57	0.57	0.86
lung, right lower lobe, adult, donor1	10075-102A3	7.33	11.91	1.37	3.67	2.75	0.00
lymph node, adult, donor1	10077-102A5	7.57	8.52	2.84	1.89	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	5.48	11.40	2.41	1.75	1.97	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	4.68	11.47	2.26	1.66	0.91	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.89	11.89	2.55	1.70	1.70	0.85
mature adipocyte, donor1	12231-129F8	11.54	7.10	2.66	6.22	0.00	0.00
mature adipocyte, donor2	12232-129F9	9.34	9.75	3.74	9.34	0.83	0.00
mature adipocyte, donor3	12233-129G1	9.48	12.56	4.50	8.30	0.95	0.24
mature adipocyte, donor4	12234-129G2	9.21	9.74	2.11	6.58	0.79	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	4.53	8.82	3.34	0.71	1.67	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	14.66	22.56	13.54	2.26	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	9.01	17.10	11.03	2.39	1.66	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	6.67	14.93	10.80	1.91	1.91	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	13.22	16.21	13.22	5.12	5.12	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	11.81	14.68	16.03	2.53	1.86	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	7.85	16.55	11.04	1.06	1.06	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	9.63	0.00	5.78	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	28.71	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	5.38	13.28	13.28	3.95	1.44	1.08
medulla oblongata - adult, donor10196	10174-103C3	6.49	13.63	9.09	1.95	1.95	1.30
medulla oblongata, adult, donor10252	10155-103A2	9.75	13.62	6.81	2.01	2.79	1.39
medulla oblongata, adult, pool1	10038-101F2	12.24	20.98	8.33	3.67	1.55	1.22
medulla oblongata, newborn, donor10223	10361-105F1	6.94	10.42	8.68	3.12	0.35	1.39
medulloblastoma cell line:D283 Med	10838-111E1	12.84	9.30	3.99	3.10	0.89	0.44
medulloblastoma cell line:ONS-76	10759-110E3	3.18	2.69	0.37	1.35	0.98	0.12
melanoma cell line:COLO 679	10514-107E1	10.06	9.06	3.74	1.58	2.87	0.43
melanoma cell line:G-361	10465-106H6	7.06	6.52	1.90	1.36	0.54	0.54
meningioma cell line:HKBMM	10691-109F7	7.06	5.07	3.62	3.44	0.90	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	2.64	4.41	1.76	2.64	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	2.07	12.44	2.07	3.63	2.07	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	12.74	13.50	3.68	2.76	1.38	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.36	9.27	3.27	1.64	1.09	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.70	8.70	2.07	1.24	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	15.31	6.46	4.35	1.69	1.12	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	16.56	5.78	2.70	2.12	0.77	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	19.43	15.27	4.86	4.16	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	12.36	6.52	2.92	6.52	1.03	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	8.51	6.90	2.19	2.07	0.81	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	12.47	9.15	4.11	3.32	0.93	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	8.24	12.02	2.03	4.05	1.35	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	7.11	7.82	2.13	3.41	0.85	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.87	9.88	3.29	2.63	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	7.89	8.03	4.43	2.91	0.83	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	7.33	5.59	1.05	1.40	1.40	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.94	7.96	2.25	1.02	0.82	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	5.75	6.11	0.72	2.52	1.80	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	6.83	7.03	3.21	1.03	0.62	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	1.82	5.47	0.46	2.51	1.82	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	8.81	8.39	2.52	1.68	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	10.61	8.82	2.99	2.24	1.34	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.70	7.88	3.06	2.89	0.53	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	8.10	5.89	1.47	1.47	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	2.00	8.30	2.00	3.72	2.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	9.68	9.68	3.79	4.63	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	8.22	8.68	1.37	0.91	2.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	7.67	7.67	3.07	4.09	0.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	11.26	6.81	1.83	1.57	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.70	8.01	1.85	3.39	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	10.12	9.65	3.77	2.82	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	10.15	7.78	3.72	1.35	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	11.40	7.07	4.32	1.96	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	6.49	2.78	3.71	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.69	6.63	4.61	2.02	1.44	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.04	7.36	3.12	2.01	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	8.17	8.65	4.81	1.92	1.44	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	8.80	5.13	2.20	4.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	12.42	6.71	3.36	1.68	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.87	9.01	3.28	2.05	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.45	9.45	1.72	2.58	1.72	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	13.67	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	10.33	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	12.34	6.82	1.95	2.92	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	5.82	1.45	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	14.39	8.53	2.67	2.67	2.13	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	11.45	9.81	4.09	0.82	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	6.22	6.22	1.55	2.33	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2.10	8.39	6.30	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	8.94	0.99	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	10.67	8.89	4.74	1.78	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	6.09	4.87	1.22	4.87	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.87	5.07	2.53	2.53	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.80	6.55	4.48	1.72	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	10.75	2.15	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	7.98	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	6.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.15	6.52	2.85	1.22	1.22	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	27.81	9.53	4.77	1.59	2.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.10	7.07	2.36	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.14	4.99	3.74	1.25	1.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	22.72	5.35	2.67	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	9.46	2.37	3.55	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	10.27	0.00	7.70	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	4.13	2.07	2.75	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.92	8.41	0.99	4.45	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	7.85	2.24	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	6.36	11.45	3.82	1.27	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	7.25	7.66	4.03	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	8.72	2.18	4.36	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	7.60	3.80	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	10.32	12.14	4.86	2.43	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	9.04	0.00	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.06	9.06	2.47	2.47	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	10.12	8.93	1.98	3.57	0.99	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	3.24	6.17	1.30	3.57	1.62	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	10.19	2.04	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	2.32	3.87	3.09	3.09	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	3.54	9.69	1.18	6.61	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.99	6.72	2.78	5.79	2.09	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	8.55	8.55	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	17.47	9.14	4.21	9.76	2.36	0.10
mesothelioma cell line:Mero-25	10850-111F4	15.21	5.45	4.31	4.31	2.50	0.00
mesothelioma cell line:Mero-41	10851-111F5	4.16	7.82	2.20	3.18	1.22	0.00
mesothelioma cell line:Mero-48a	10852-111F6	1.33	4.43	1.55	0.89	1.77	0.00
mesothelioma cell line:Mero-82	10853-111F7	13.40	4.73	4.99	4.20	1.84	0.00
mesothelioma cell line:Mero-83	10854-111F8	16.17	7.15	4.43	5.79	1.87	0.17
mesothelioma cell line:Mero-84	10855-111F9	18.96	5.31	4.80	5.81	0.25	0.51
mesothelioma cell line:Mero-95	10856-111G1	11.39	9.94	3.11	2.69	1.24	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	6.46	7.12	1.49	2.32	1.99	0.33
mesothelioma cell line:NCI-H226	10846-111E9	15.20	6.52	3.62	8.87	2.17	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	9.91	8.88	3.07	4.78	1.37	0.17
mesothelioma cell line:NCI-H28	10845-111E8	7.38	5.60	2.80	1.78	1.02	0.25
mesothelioma cell line:No36	10857-111G2	6.85	9.79	0.98	3.26	0.98	0.00
mesothelioma cell line:ONE58	10858-111G3	4.06	6.77	2.44	3.25	0.81	0.27
migratory langerhans cells, donor1	11901-125F2	4.03	8.64	1.54	1.15	0.96	0.19
migratory langerhans cells, donor2	11902-125F3	1.10	6.72	1.59	0.85	0.98	0.24
migratory langerhans cells, donor3	11903-125F4	8.26	6.82	3.59	0.72	0.36	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	13.06	11.75	4.90	4.57	2.94	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	19.07	8.27	6.36	4.45	1.70	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	5.76	3.69	2.76	5.30	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	9.32	6.85	5.90	2.47	0.38	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	45.09	15.34	5.73	11.64	3.51	0.18
myeloma cell line:PCM6	10474-106I6	30.24	21.94	9.29	7.91	4.35	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	13.70	7.61	2.54	3.04	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	13.14	6.67	4.12	3.92	0.59	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.70	6.57	1.34	2.67	1.89	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	12.43	9.27	1.84	2.94	1.91	0.37
nasal epithelial cells, donor2	12227-129F4	14.90	6.07	2.21	1.10	2.76	0.00
neuroblastoma cell line:CHP-134	10508-107D4	22.32	13.11	7.13	2.99	0.92	0.69
neuroblastoma cell line:NB-1	10539-107G8	6.36	14.97	2.99	7.11	0.94	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	23.62	8.44	3.16	3.59	2.53	0.42
neuroblastoma cell line:NH-12	10555-107I6	15.47	12.49	3.35	1.86	0.75	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	26.57	12.57	3.80	2.14	0.95	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	15.20	11.25	3.64	2.69	0.95	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	56.55	19.92	5.23	8.05	1.01	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.81	6.99	0.64	2.54	1.91	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	5.86	5.06	1.86	2.40	0.80	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	18.94	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	5.07	38.56	3.72	5.07	4.74	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1.60	20.01	3.20	0.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	11.54	7.69	2.56	0.00	1.28	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	13.93	9.20	7.62	3.94	2.10	0.26
nucleus accumbens, adult, pool1	10037-101F1	11.34	21.75	12.19	2.72	1.69	1.69
occipital cortex - adult, donor10196	10172-103C1	16.48	22.66	18.54	2.06	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	11.54	17.44	10.20	1.88	1.88	2.42
occipital cortex, newborn, donor10223	10355-105E4	4.37	12.74	13.47	5.10	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	7.35	17.84	11.28	0.79	0.52	1.57
occipital lobe, fetal, donor1	10073-102A1	6.01	13.73	7.29	3.43	1.29	0.43
occipital pole, adult, pool1	10036-101E9	14.27	18.76	11.98	1.66	1.26	1.42
olfactory region, adult	10195-103E6	7.45	17.96	8.60	0.76	1.34	1.15
optic nerve, donor1	10277-104E7	0.00	20.01	2.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	16.86	7.40	2.73	3.42	1.48	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	36.54	8.66	9.89	2.89	0.41	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	24.55	14.56	4.06	3.22	2.03	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	9.70	5.20	0.92	1.27	1.16	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	5.29	4.12	1.76	3.23	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	5.61	1.87	0.93	0.93	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	22.27	7.42	3.61	5.09	1.70	1.06
ovary, adult, pool1	10020-101D2	16.77	7.69	3.76	1.75	1.31	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	10.27	11.73	2.20	3.85	0.73	0.55
pancreas, adult, donor1	10049-101G4	13.17	16.93	9.41	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	20.41	4.75	5.03	5.31	1.68	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	7.84	8.01	3.58	1.87	2.56	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	8.78	4.80	3.97	2.48	0.66	0.00
paracentral gyrus, adult, pool1	10035-101E8	13.09	22.79	14.64	1.46	2.38	2.01
parietal cortex, adult, donor10258	10373-105G4	8.07	21.29	8.81	2.94	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	11.29	15.05	10.35	1.88	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	11.40	16.53	7.70	3.14	2.28	0.86
parietal lobe, adult, pool1	10034-101E7	11.19	21.77	14.98	1.59	2.38	1.59
parietal lobe, fetal, donor1	10072-101I9	7.76	9.70	11.64	2.91	2.91	0.97
parietal lobe, newborn, donor10223	10356-105E5	8.22	15.70	10.47	2.62	0.75	0.37
parotid gland, adult	10199-103F1	7.40	12.33	6.17	0.00	2.47	0.00
penis, adult	10200-103F2	11.82	10.21	6.98	4.83	2.15	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	20.08	13.95	5.21	2.42	0.56	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.80	19.52	5.39	2.48	4.23	0.15
pineal gland - adult, donor10196	10179-103C8	4.52	14.19	3.87	1.29	1.29	1.29
pineal gland, adult, donor10252	10160-103A7	10.07	29.02	11.84	1.18	2.37	2.37
pineal gland, adult, donor10258	10377-105G8	6.90	18.81	11.91	3.14	3.76	1.25
pituitary gland - adult, donor10196	10180-103C9	15.18	11.13	10.12	6.07	1.01	2.02
pituitary gland, adult, donor10252	10162-103A9	18.76	22.93	18.24	3.13	3.65	2.61
pituitary gland, adult, donor10258	10378-105G9	10.21	24.69	22.13	9.36	2.55	1.70
placenta, adult, pool1	10021-101D3	6.99	14.94	2.90	9.14	1.29	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	8.34	7.02	5.03	2.38	0.40	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	3.27	6.85	2.49	1.87	0.78	0.16
pons, adult, pool1	10033-101E6	10.59	22.29	9.55	3.18	2.07	0.77
postcentral gyrus, adult, pool1	10032-101E5	12.64	19.09	14.47	1.66	2.09	1.57
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	0.00	0.00	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	16.52	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	16.46	11.65	7.72	5.24	1.75	0.58
prostate cancer cell line:PC-3	10439-106E7	9.26	8.89	5.99	8.89	2.00	0.54
prostate, adult, pool1	10022-101D4	14.24	11.16	5.44	2.63	1.81	0.18
putamen, adult, donor10196	10176-103C5	6.37	18.18	10.39	3.07	1.18	0.71
putamen, adult, donor10252	10152-102I8	15.69	9.80	7.84	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	8.74	10.93	0.00	2.19	2.19	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	7.01	14.74	6.04	0.72	2.42	0.24
putamen, newborn, donor10223	10365-105F5	14.99	32.99	13.49	9.00	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	18.04	6.69	1.45	3.49	0.29	0.00
rectum, fetal, donor1	10067-101I4	8.35	13.91	5.56	5.56	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	6.15	5.72	2.54	1.70	0.42	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	4.97	5.80	3.31	0.41	0.83	0.00
retina, adult, pool1	10030-101E3	16.10	16.10	9.94	2.88	2.39	0.20
retinoblastoma cell line:Y79	10475-106I7	13.25	14.81	5.46	1.82	0.52	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.30	6.02	6.52	4.18	0.98	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	6.75	4.22	2.53	7.31	0.00	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	4.55	2.27	0.76	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	12.62	8.90	1.29	0.81	1.13	0.16
salivary acinar cells, donor2	11772-123I8	21.75	9.50	5.37	0.96	2.20	0.14
salivary acinar cells, donor3	11773-123I9	10.59	3.31	1.99	0.66	1.32	0.66
salivary gland, adult, pool1	10093-102C3	18.30	25.74	4.00	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	27.06	13.74	8.35	1.69	2.36	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	25.74	17.63	10.23	1.29	2.82	1.06
seminal vesicle, adult	10201-103F3	12.17	16.40	5.82	5.29	2.65	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	4.37	5.59	1.94	0.97	0.73	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	5.03	3.77	1.01	0.75	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	4.01	12.04	3.01	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	15.85	10.07	4.16	1.61	1.34	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	2.32	5.97	1.99	6.74	0.99	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	16.90	6.71	3.61	9.16	1.81	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	3.55	2.84	0.71	3.55	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	9.12	5.16	1.68	3.36	0.96	0.00
skeletal muscle, fetal, donor1	10066-101I3	13.07	5.03	1.01	4.02	0.00	0.00
skin, adult, donor1	10074-102A2	0.00	20.36	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	6.94	7.57	1.26	4.42	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	2.33	6.67	3.34	3.34	1.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	14.18	14.50	8.20	4.41	2.52	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.63	7.71	6.94	1.35	0.00	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	9.40	9.72	3.13	4.12	1.98	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	7.72	11.58	2.41	0.97	0.80	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	5.88	12.42	3.27	5.23	1.96	0.87
small intestine, adult, pool1	10024-101D6	5.61	20.19	4.30	9.44	6.57	0.12
small intestine, fetal, donor1	10064-101I1	10.32	10.81	4.42	2.95	2.95	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	3.08	16.41	3.08	4.62	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	9.05	11.11	3.62	3.10	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	1.61	6.70	2.14	5.36	1.07	0.27
spinal cord - adult, donor10196	10181-103D1	4.13	14.22	3.67	3.21	1.61	0.23
spinal cord, adult, donor10252	10159-103A6	10.65	16.95	7.49	0.79	1.18	2.37
spinal cord, adult, donor10258	10369-105F9	13.14	29.06	8.99	1.38	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	3.66	10.98	3.66	6.10	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	5.97	25.72	11.02	4.59	1.84	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	3.88	5.08	0.60	1.94	1.34	0.00
spleen, adult, pool1	10025-101D7	13.33	12.34	2.75	5.51	2.20	0.11
spleen, fetal, pool1	10044-101F8	9.22	14.22	3.02	4.05	2.54	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.73	6.83	4.97	2.48	0.52	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	33.04	18.04	9.68	5.32	2.47	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	10.13	9.44	4.19	2.10	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	30.10	5.86	6.25	1.95	3.13	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	6.30	11.48	2.81	1.01	2.14	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	4.66	7.20	5.08	1.27	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	6.77	4.65	2.12	2.54	1.27	0.42
stomach, fetal, donor1	10062-101H8	3.20	8.54	0.00	2.14	1.07	0.00
submaxillary gland, adult	10202-103F4	8.55	15.95	1.14	1.71	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	8.52	25.13	5.82	3.32	3.12	0.62
substantia nigra, adult, donor10258	10371-105G2	7.76	20.69	7.76	4.14	1.03	1.55
substantia nigra, newborn, donor10223	10358-105E7	2.83	17.66	5.65	2.12	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	8.02	8.48	5.04	4.36	0.69	0.69
temporal lobe, adult, pool1	10031-101E4	13.90	20.43	12.89	1.86	2.03	1.44
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	6.41	8.55	4.99	2.14	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	8.79	11.43	6.15	2.20	0.44	0.88
tenocyte, donor1	11763-123H8	13.96	12.22	2.44	3.49	1.05	0.35
tenocyte, donor2	11765-123I1	14.50	11.83	3.82	6.49	1.53	0.00
tenocyte, donor3	11768-123I4	7.41	11.86	1.11	6.67	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	14.11	3.23	5.27	2.04	0.34	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	71.22	13.26	14.64	3.39	1.23	1.23
teratocarcinoma cell line:PA-1	10807-111A6	27.74	5.42	6.35	1.24	0.62	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	8.00	3.81	1.40	5.33	0.76	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	16.26	6.81	3.78	0.00	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	16.58	2.84	1.09	0.87	0.33	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	8.14	2.61	1.95	0.00	1.63	0.00
testis, adult, pool1	10026-101D8	8.70	6.23	5.15	5.26	0.54	1.40
testis, adult, pool2	10096-102C6	6.77	6.32	5.41	9.92	1.35	0.45
thalamus - adult, donor10196	10168-103B6	3.31	14.35	6.62	4.42	4.42	3.31
thalamus, adult, donor10252	10154-103A1	6.56	21.57	10.16	2.97	1.41	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	21.55	4.62	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	7.25	11.86	6.59	1.81	0.82	1.48
thalamus, newborn, donor10223	10366-105F6	4.60	4.03	8.05	5.75	1.73	0.00
throat, adult	10209-103G2	8.99	8.99	3.00	4.49	0.75	0.50
throat, fetal, donor1	10061-101H7	6.09	12.80	3.66	7.92	1.83	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	32.99	8.74	13.91	0.99	1.59	0.40
thymus, adult, pool1	10027-101D9	7.95	20.78	3.98	3.28	2.88	0.50
thymus, fetal, pool1	10043-101F7	12.99	20.68	6.03	4.26	2.70	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	9.71	10.50	1.73	2.79	1.46	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	46.38	14.81	11.04	3.63	4.19	0.84
thyroid, adult, pool1	10028-101E1	34.81	23.51	16.61	3.92	1.87	1.59
thyroid, fetal, donor1	10060-101H6	11.07	12.92	8.70	3.16	1.05	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	3.08	0.00	3.08	3.08	0.00
tongue, adult	10203-103F5	3.49	8.14	1.63	2.09	1.40	0.23
tongue, fetal, donor1	10059-101H5	2.36	11.82	1.97	3.55	0.79	0.39
tonsil, adult, pool1	10047-101G2	12.42	19.23	4.51	2.60	2.80	0.30
trachea, adult, pool1	10029-101E2	9.00	12.92	4.42	2.54	1.88	0.41
trachea, fetal, donor1	10058-101H4	5.77	7.31	3.08	6.54	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	7.79	6.02	3.90	2.48	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	15.20	6.59	3.14	4.46	0.91	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	38.39	14.10	11.59	10.50	3.13	0.78
tridermal teratoma cell line:HGRT	10694-109G1	5.71	1.90	1.90	1.90	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	11.34	5.50	2.96	1.52	0.68	0.42
umbilical cord, fetal, donor1	10057-101H3	8.35	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	17.75	14.67	4.95	2.73	0.68	0.34
uterus, fetal, donor1	10055-101H1	6.14	6.66	2.05	4.10	2.05	1.54
vagina, adult	10204-103F6	6.46	5.82	1.94	8.40	0.00	0.00
vein, adult	10191-103E2	4.16	11.40	3.29	7.67	1.75	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	21.10	5.34	6.41	1.60	1.07	0.27